Home | UMD School of Public Health



ELBERT D. GLOVER 10/1/14

2005-present - UNIVERSITY OF MARYLAND COLLEGE PARK

SCHOOL OF PUBLIC HEALTH

Professor, Department of Behavioral & Community Health, Sch of Public Health, 2005-present

Professor, Department of Epidemiology and Public Health, School of Medicine, 2013-present

Chair, Department of Behavioral & Community Health, 2005-present

Founding Director, Center for Health Behavior Research, 2005-present

Member, College Strategic Planning Committee, 2005-08

Member, College/School Administrative Council, 2005-present

Member, College Chair for Family Studies Review Committee, 2005-06

Member, Search Committee 6 New Positions for the School of Public Health, 2006-07

Chair, Environmental Health Search Committee, 2006-07

Chair, Epidemiology Search Committee, 2007-08

Member, University Senate, 2007-08

Member, University Honor Board, 2010-present

Address

University of Maryland School of Public Health

Department of Behavioral & Community Health

2387 HHP Valley Drive

College Park, MD 20742 USA

Phone: 301.405.2467; Fax: 301.314.9167

E-mail: eglover1@umd.edu

Departmental Web site:

Center for Health Behavior Research Web site:

EDUCATION:

B.A. Texas Tech University, Lubbock, TX – 1969 (Health Education)

M.A. Texas A & I University, Kingsville, TX – 1972 (Health Education)

Ph.D. Texas Woman’s University, Denton, TX – 1977 (Health Education)

SPECIAL TRAINING:

Structured Clinical Interview for Axis I DSM-IV Disorder (SCID), 1994

Mini International Neuropsychiatric Interview (MINI), 1999

Hamilton Rating Scale for Depression (HAM-D), 1999

Hamilton Anxiety Scale (HAM-A), 1999

Montgomery Asberg Depression Rating Scale (MADRS) 2000

NIH’s Human Participants Protection Education for Research Teams Training, February 2001

Association of Clinical Research Professionals, Good Clinical Practices for Clinical Investigators

3-day Training, 2002

PREVIOUS PROFESSIONAL EXPERIENCE:

1990-2005 WEST VIRGINIA UNIVERSITY

ROBERT C. BYRD HEALTH SCIENCES CENTER

SCHOOL OF MEDICINE

BEHAVIORAL MEDICINE & PSYCHIATRY

Professor, Department of Behavioral Medicine & Psychiatry, 1990-2005

Professor, Department of Family Medicine, 1998-2005

Founding Director, Addiction & Psychiatric Medicine Research Center, 2001-05

Associate, Center for Addictions, Chestnut Ridge Hospital 1990-2005

Director & Founder, Tobacco Research Center, MBR Cancer Center, 1990-1999

Founding Director, Clinical Trials Research, Behavioral Med & Psychiatry, 1999- 01

Member, University Smoking Task Force, 1993

Member, University Smoking Cessation & Education Committee, 1993

Member, Sch of Med Continuing Medical Educ Committee, 1993-1995

Member, Departmental Faculty Development Committee, 1994-1995

Member, University Stadium Smoking Policy Task Force, 1994

Committee Member, Epidemiologist Search Committee, Institute of Occupational & Environmental Health, 1994-95

Chair, Tobacco Demonstration Project Coordinator Search Committee, 1995

Chair, Research Lecturer Search Committee, 1995

Member, Health Science Research Integrity Committee, 1997-1998

Member, Health Science Discovery Committee, 1998-2002

Member, University Institutional Review Board for the Protection of Human

Subjects, 1999-2002

Member, Sch of Med, Intramural Clinical Research Committee, 2000-02

Member, Prevention, Education, & Outreach Committee, MBRCC, 2001-2002

Member, Academic Executive Committee, Beh Med & Psychiatry, 2001-2005

Member, University Scientific Protocol Review Committee (SPRC), 2002-2005

Member, School of Medicine Promotion & Tenure Committee, 2003-2005

Member, School Committee on PhD in Public Health Sciences, 2004-2005

Member, Executive Committee, Implementation of Electronic IRB (BRAAN2), 2003-2004

MARION MERRELL DOW PHARMACEUTICALS renamed; HOECHST, MARION, ROUSSELL

National Visiting Professor, 1991-1996

Advisory Committee, 1992-1996

CIBA-GEIGY SELF-CARE renamed: NOVARTIS

Medical Series Lecturer, 1991-1999

PARKE-DAVIS

Speaker’s Bureau, 1992-1994

Advisory Committee, 1992-94

LEDERLE LABORATORIES

National Faculty Forum, 1992-94

COLLEAGUE MEDICAL

Moderator & Lecturer Series Speaker, 1994

SMITHKLINE BEECHMAN CONSUMER HEALTHCARE

Lecturer, 1995-1999

GLAXO WELLCOME (renamed, GlaxoSmithKline)

Smoking Cessation Advisory Panel, 1996-2000

National Speakers Bureau, 1997-2001

GLAXO SMITH KLINE (GSK)

Key Opinion Leader, 2003-2004

SANOFI-SYNTHELABO (renamed Sanofi-Aventis)

International Nicotine Dependence Advisory Board, 2001-2006

International Operational Committee, 2001-2006

PFIZER INC.

Regional Advisory Board, 2006-2013

Speaker, 2006-present

1988-90 THE PENNSYLVANIA STATE UNIVERSITY

Professor, Health Education, 1988-90

Senior Member, Graduate Faculty, 1988-90

Director, Centre for Tobacco Research, 1988-90

1985-88 EAST CAROLINA UNIVERSITY

Professor, Community Health, Promoted 1988

Adjunct Associate Professor, Dept of HPERS, 1985-88

Adjunct Associate Professor, Rehab Studies, 1987-88

Coordinator, Departmental Research, 1985-88

Member, Graduate Review Committee, 1985-88

Member, School Computer Committee, 1985-88

Member, School Curriculum Committee, 1985-88

Member, University Graduate Faculty, 1985-88

Member, Chancellor’s Ad Hoc Committee, AIDS, 1986-88

Subcommittee, Health Professionals Affairs

Subcommittee, AIDS Education

Member, University Gerontology Committee, 1986-87

Member, School Committee, Faculty Evaluation, 1986

Member, School Committee To Study Merit Pay, 1987

Member, University Research Committee, 1987-88

Chairperson, School Curriculum Committee, 1987-88

1983-84 OKLAHOMA HEALTH SYSTEMS AGENCY

Coordinator, SAC II

1982-83 OKLAHOMA STATE UNIVERSITY

Chairperson, Health Department, 1982-83

Associate Professor, 1982-83

Member, University Graduate Faculty, 1982-83

Member, School Faculty Development Committee, 1982-83

Member, School Academic Council, 1982-83

Member, School PhD Committee, 1982-83

Member, School Personnel & Policies Committee, 1982-83

Member, University Grad Gerontology Committee, 1982-83

1978-82 TEXAS CHRISTIAN UNIVERSITY

Director, Health Education, 1978-82

Assistant Professor, Health Education, 1978-82

Member, University Graduate Faculty, 1979-82

Member, University Human Research Committee, 1979-82

Chair, University Human Research Committee, 1981-82

TEXAS WOMAN’S UNIVERSITY

Visiting, Assistant Professor, Health Education, Summer, 1979

TEXAS COLLEGE OF OSTEOPATHIC MEDICINE

Visiting Lecturer, Preventive Medicine, Fall, 1980

1976-78 UNIVERSITY OF KANSAS

Assistant Professor, Health Education, 1976-78

Member, University Human Sexuality Consortium, 1976-78

Member, Chair Review Committee, Sch of Ed, 1977-78

Member, Graduate Faculty, 1977-78

Member, Subcommittee, Faculty Senate Research, 1978

Member, Sch Grad Student Exit Committee, 1977-78

1975-76 TEXAS A & M UNIVERSITY

Visiting Lecturer, Health Education

ACTIVE MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS:

American Association of Health Education, 1976-present

Member, Planning Committee, 93rd Convention, AAHPERD, 1978

Member, Research Council, Southern District, AAHPERD, 1983-89

Elected, Health Council, Southern District, AAHPERD, 1988-89

Member, AAHPERD Research Consortium, 1988-present

Past Chair, Community Health Council, SDAAHPERD, 1989-90

Elected Fellow, AAHPERD Research Consortium, 1991

Panel Chair, Research Consortium, Health Abstracts, 1999 for 2000 convention

Panel Chair, Research Consortium, Health Abstracts, 2000 for 2001 convention

Panel Chair, Research Consortium, Health Abstracts, 2001 for 2002 convention

Presider, Free Communication Research Consortium, AAHPERD, 2000, ‘01, ‘02, ‘03

Member, Research Consortium Nominating Committee, 2001

Member, Research Coordinating Board, 1997-2000

Service to the AAHE Research Coordinating Board, Annual Meeting, 2000

Reviewer, AAHE Research Consortium Abstracts, 2001 for 2002 convention

Member, AAHE Research Consortium

Presider, Worksite Health, for 2002 convention

Awarded, AAHE Distinguished Scholar, 2003

Member, AAHPERD Research Consortium Ethics Committee, 2002-2010

Member, AAHPERD Research Consortium Nominating Committee, 2002-2004

Selected, Cadre of Experts for AAHE, 2002-present

Member, Associate Board of Editors, American Journal of Health Education, 2004-07

Awarded, Alliance Scholar, AAHPERD, 2005

American School Health Association, 1973-Life Member

Member, Committee on Drugs, 1977-89

Elected Fellow, 1978

Member, Committee on School Health Education, 1978-85

Member, Research Council, 1978-present

Member, Committee on Aging & Death Education, 1979-85

Chairperson, 1983-85

Member, Committee on International Health, 1986-89

Member, Council on Health Behaviors, 1989-93

Member, International Health Council, 1989-92

Member, Research Council Executive Committee, 1990-95

Member, Council on Alcohol, Tobacco, & Other Drugs, 1993-95

Reviewer, Abstracts for the 76th Annual National Conference, 2002

Member, Research Awards Committee, 2004

American Public Health Association, 1977-present

Member, Public Health Committee

Anti-Tobacco Force Initiative Task Force

Society of Behavioral Medicine, 1985-2005

WVU Campus Representative 1992-2005

Council of Biology of Editors, 1992-1999

Renamed Council of Science Editors, 2002-2005

American Medical Writers Association, 1993-2005

National Wellness Association, 1994-2005

Society for Research on Nicotine & Tobacco, 1994-present

Member, Publications Committee, 1994-95; 2002-05

Member, Volunteer Committee, 1998-95

Volunteer Coordinator, 1999-95

Member, Development Committee, 1999-2001

Chair, Development Committee, 2001-07

Member, Membership Committee, 1999-95

Member, Full Board, 2001-07

American Academy of Health Behavior, 1997-present

Founder, 1997

President, 1997-2002

Member, Executive Board, 1997-2003

Member, Full Board, 1997-2003

Elected Fellow, 1998

Awarded, Lifetime Achievement Award, 2000

Immediate Past President, 2002-2003

Member, Membership Committee, 2007-2008

Chair, Membership Committee, 2009-2012

Royal Society for Public Health, 2002-present

Elected Fellow, 2002

Association for the Treatment of Tobacco Use & Dependence 2003-2005

Metropolitan Washington Public Health Association, 2006-present

International Union for Health Promotion and Education, 2008-present

PROFESSIONAL JOURNAL ACTIVITY:

Reviewer, Journal of School Health, 1978-present

Reviewer, Journal of Drug Education, 1978-2010

Editorial Consultant, Journal of Drug Education, 1981-94

Reviewer, Health Education, renamed, American Journal of Health Education, 1986-present

Ad Hoc Reviewer, American Journal of Public Health, 1987-present

Ad Hoc Reviewer, The Physician & Sportsmedicine, 1987-present

Ad Hoc Reviewer, Journal of the American Medical Association, 1988-present

Editor-in-Chief, Wellness Perspectives, 1989-95

Publisher, Wellness Perspectives, 1989-95

Publisher, Health Values, 1989-95

Ad Hoc Reviewer, Addictive Behaviors, 1989-present

Ad Hoc Reviewer, Health Education Research: Theory & Practice, 1989-present

Ad Hoc Reviewer, Journal of American College Health, 1990-present

Editor-in-Chief, Health Values, 1990-95

Ad Hoc Reviewer, NCI Journal, 1991-present

Ad Hoc Reviewer, Public Health Reports: Journal of the Pub Hlth Service, 1992-present

AD Hoc Editorial Board, Clinical Advances in Smoking Cessation, 1992-present

Ad Hoc Reviewer, Medical Self-Care, 1992-present

Editor, Smoking Cessation Update, 1993

Ad Hoc Reviewer, The Journal of Family Practice, 1995-present

Ad Hoc Reviewer, Addiction, 1995-present

Columnist, Smoke-Free Times, Q&A Tobacco Column, Tobacco-Free WV, 1995-2000

Publisher, American Journal of Health Behavior, 1996-present

Editor-in-Chief, American Journal of Health Behavior, 1996-present

Editorial Board, American Journal of Health Studies 1995-present

Ad Hoc Reviewer, Journal of Alcohol & Drug Education, 1996-05

Ad Hoc Reviewer, Advances in Dental Research, 1996-present

Ad Hoc Reviewer, Mayo Clinic Proceedings, 1997-present

Ad Hoc Review Board, CHES Bulletin, 1997-present

Ad Hoc Reviewer, Southern Medical Journal, 1997-present

Ad Hoc Reviewer, Nicotine & Tobacco Research, 1998-present

Ad Hoc Reviewer, American Journal of Managed Care, 2001-present

Member, CHES Bulletin Review Board, National Commission for Health Education

Credentialing, 1998-2000.

Ad Hoc Reviewer, Journal of Alcohol & Drug Education, 2001-present

Ad Hoc Reviewer, Lancet, 2007-present

Previously Served on State Review Boards of KAHPERD, TAHPERD, OAHPERD

& The North Carolina Journal

Editorial Board Member, Drugs & Studies, 2010-present

Ad Hoc Reviewer, Journal of Harm Reduction, 2011-present

Ad Hoc Reviewer, Australian and New Zealand Journal of Public Health, 2011-present

Ad Hoc Reviewer, Informa, 2011-present

Ad Hoc Reviewer, Psychopharmacology, 2011-present

Editorial Board Member, World Journal of Translational Medicine, 2012-present

Executive Editor, Health Behavior and Policy Review, 2012-present

Publisher, Health Behavior and Policy Review, 2012-present

Executive Editor, Tobacco Regulatory Science, 2014-present

Publisher, Tobacco Regulatory Science, 2014-present

PARTICIPATION IN PROFESSIONAL ENDEAVORS:

Member, Board of Directors, Kansas American Cancer Society, 1977-80

Ex-Officio Board Member, Kansas Lung Association, 1978-79

Member, Committee Alcohol & Drug Abuse, State Department of Social &

Rehabilitation Services, State of Kansas, 1978

Co-founder, Tarrant County Group Against Smoker’s Pollution, 1979

Elected President, 1979-82

Chairman, Smoking & Health, Texas American Cancer Society, 1979-82

Member, Public Education Committee, 1972-82

State Judge, Larry Hagman Quit Smoking Contest, 1981

Member, Board of Directors, Tarrant County, American Cancer Society, 1979-82

Keynote Speaker, Annual Youth Against Cancer Conference: 1980, San Antonio; 1981,

Dallas; 1982, Austin

Member, National People’s Medical Society Advisory Committee, 1982-86

Member, Oklahoma Governor’s Task Force, Fitness, 1983-84

Member, Health & Nutrition Advisory Committee, Oklahoma State Dept of Ed, 1983-84

Advisor, Metropolitan Public Broadcasting, WQED, Pittsburgh, 1983-84

Member, Health for the Young, American Heart Assoc, Oklahoma Division, 1984-85

Member, Education Committee, Oklahoma American Cancer Society, 1984-85

Chair, Computer Committee, 1984

Member, Oklahoma Health Education Advisory Council, 1983-84

Elected Secretary, 1983-84

Appointed Chief Editor, OHEAC NEWS, 1983-84

Elected Publicity Committee Chairperson, 1984

Guest Editor, Health Values, “Dental Health,” Jan-Feb, 1984

Elected, Board of Directors, North Carolina American Cancer Society, 1986-88

Member, Board of Directors, Pitt County, 1985-88

Member, Public Education Committee, 1985-88

Chairperson, State Evaluation Sub-Committee, 1985-87

Appointed, National Advisory Committee on Smokeless Tobacco, American Cancer Society, UCLA, Los Angeles, 1986-1988

Gateway Coordinator, 13th World Conference on Health Education, Houston, 1986-88

Elected, Board of Directors, North Carolina American Lung Association, 1988-90

Member, Planning Committee, 1st Internat’l Conference on Smokeless Tobacco, 1988-90

Member, Office of Minority Health Resource Center (OMH-RC) Network, Department of HHS, PHS, Office of the Assistant Secretary of Health, 1988-98

Elected, Scientific Board of Directors, Pennsylvania American Cancer Society, 1990

Member, Board of Directors, Centre County, PA, 1989-90

Member, West Virginia American Cancer Society Board of Directors, 1990-2005

Public Education Committee, 1990-95

Professional Education Committee, 1990-95

Public Policy Committee, 1992-95

Member, Monongalia American Cancer Society Board of Directors, 1990-2005

President-Elect, 1991-92; President, 1992

Member, PATCH Partner, Monongalia County, 1991-98

Member, West Virginia Tobacco Coalition, 1991-94

Member Advisory Board, Tobacco Intervention Network, 1991

Convocation Speaker, Smokeless Tobacco, Davis & Elkins College, 1991

Member, “Expert Advisory Group on the Essential Elements of Spitting Tobacco Prevention & Cessation Programs,” Public Health Service, National Institutes of Health, NCI, 1992

Contributing Author, 1994 Surgeon General’s Report on Adolescent Smoking, 1994

Member, WV Youth Tobacco Prevention Campaign, Advisory Committee, 1994-2005

Member, Coalition for a Tobacco-Free West Virginia, 1994-2005

Member, Board of Directors, Applied Behavioral Science Press, 1996-2005

Panel Member, Tobacco Without Fire: Dangerous, Useful, or Both? Second International Conference on Smokeless/Spit Tobacco (Invitation), 2000

Member, National Cancer Institute / National Institute of Drug Abuse, Working Group on Pharmacologic Approaches to Nicotine Addiction, 2001-2005

Member, Cessation/Nicotine & the Science of Addiction Subcommittee, 2002 National Conference on Tobacco or Health, San Francisco, 2002

Member, Increasing Diversity/Eliminating Disparities Subcommittee, 2002 National Conference on Tobacco or Health, San Francisco, 2002

Member Research Review Panel, Office of Extramural Prevention Research, Centers for Disease Control & Prevention, Atlanta, 2002

Review Panel Member, Virginia Tobacco Settlement Foundation, Grant Reviewer for State Tobacco Grants, May-July, 2002

Reviewer, The Nation’s Investment in Cancer Research: A Plan & Budget Proposal for Fiscal Year 2004

Member, External Advisory Board, Ohio State University Comprehensive Cancer Center 5-Year National Cancer Grant to Examine Issues Related to Cervical Cancer Screening among Women Living in Appalachian Ohio, “Community Access, Resources, & Education (CARE)” 2004-2009.

Guest Speaker, Warner Series, “Varenicline & and New Treatment Options for Treating Nicotine Dependence.” American Legacy Foundation, Washington DC, 2006

External Program Reviewer, Graduate Program Self-Study, University of Oklahoma Health Sciences Center, College of Public Health, Department of Health Promotion Sciences, Oklahoma City, OK, 2007

Invited Speaker, “The Art of Publishing” 10th Annual Faculty Forum, Research and Collaborative Activities, Clemson SC, 2008

Member, External Advisory Board, Ohio State University, National Institutes of Health-Supported Centers for Population Health and Health Disparities (CPHHD) to Examine Issues Related to Cervical Cancer Screening among Women Living in Appalachian Ohio, “Reducing Cervical Cancer in Appalachia)” 2010-present

Distinguished Speaker, “Publishing in Professional Journal” Kent State University, 2014

Distinguished Speaker, “Treating Nicotine Dependence: Helping Smokers Quit” Kent State University, 2014

Invited Medical Grand Rounds Throughout the US

(1991)

Chestnut Ridge Hospital, Morgantown, WV; Riverside Methodist Hospital, Columbus, OH; Grandview Osteopathic Hospital, Dayton, OH; St. Elizabeth Medical Center, Dayton, OH; Green Memorial Hospital, Dayton, OH; Wright-Patterson Air Force Medical Center, Dayton, OH; United Hospital Center, Clarksburg, WV; Beckley Appalachian Regional Hospital, Beckley, WV; West Virginia University School of Medicine, Department of Medicine, Morgantown, WV; Chestnut Ridge Hospital, Morgantown, WV; Weirton Medical Center, Weirton, WV; Baptist Regional Hospital, Pensacola, FL; Pulmonary & Critical Care Medicine, West Virginia University School of Medicine, Morgantown, WV; Gallapolis Medical Society, Gallapolis, OH.

(1992)

Garrett County Memorial Hospital, Oakland, MD; Brownsville General Hospital, Brownsville, PA; St. Joseph’s Hospital, Parkersburg, WV; Huntington Internal Medicine Group, Huntington, WV; Southern WV Pharmacists Association, Huntington, WV; East Liverpool Hospital, East Liverpool, OH; Meadville Medical Center, Meadville, PA; DuPont International Physicians, Wilmington, DE; Sacred Heart Hospital, Pensacola, FL; Washington Hospital, Washington, PA; West Penn Hospital, Pittsburgh, PA; Marion County Medical Society, Fairmont, WV; Conemaugh Valley Memorial Hospital, Johnstown, PA; Citizens General Hospital, New Kensington, PA; Department of Family Medicine, West Virginia University School of Medicine, Morgantown, WV; Mt. Diablo Medical Center, Concord, CA; South Side Hospital, Pittsburgh, PA; Magee Women’s Hospital, Pittsburgh, PA; Long Island Osteopathic Hospital, New York, NY; Mercy Hospital, San Diego, CA; St. Francis Hospital, Charleston, WV; Charleston Area Medical Center, Charleston, WV; Logan General Hospital, Logan, WV; Deaconess Hospital, Cincinnati, OH; University Hospital, Cincinnati, OH; Beaver Medical Center, Beaver, PA; St. Clair Hospital, Pittsburgh, PA; Grandview Hospital, Cincinnati, OH; Kettering Hospital, Kettering, OH; Veterans Administration Medical Center, Pittsburgh, PA; St. Elizabeth Hospital Medical Center, Youngstown, OH; Weirton Medical Center, Weirton, WV; West Hills Passavant Hospital, Pittsburgh, PA; Lankenau Hospital, Wynnewood, PA; Sarasota Memorial Hospital, Sarasota, FL; Einstein Medical Center, Philadelphia PA; Easton Hospital, Easton, PA; Medical Center, Solon, OH; Latrobe Area Hospital & Jefferson Medical College, Latrobe, PA; Lancaster General Hospital, Lancaster, PA; Southern Illinois University, Memorial Hospital, Springfield, IL; Southern Illinois University, Psychiatry Unit, Springfield, IL; Hospital of the University of Pennsylvania, Philadelphia, PA; The Washington Hospital, Washington, PA; St. Albans Psychiatric Hospital, Radford, VA; McKeesport Hospital, McKeesport, PA; Department of Veterans Affairs, James E. VanZandth Medical Center, Altoona, PA; Alderson-Broaddus College, Health Sciences Center, Philippi, WV; Temple University School of Medicine, Philadelphia, PA; University of Maryland, School of Medicine, Baltimore, MD; Marshall University, School of Medicine, Huntington, WV; St. Mary’s Hospital, Huntington, WV; Montgomery General Hospital, Montgomery, WV; Mount Carmel Health, Columbus, OH; Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL; Northern Illinois Society of Hospital Pharmacists, Chicago, IL; Riverside Hospital, Jacksonville, FL; University of Pittsburgh Medical Center, Pittsburgh, PA: Kanawah Family Practice Center, Charleston, WV; John Muir Medical Center, Walnut Creek, CA; PharMed, Cleveland, OH; Sacred Heart Hospital, Cumberland, MD; Deaconess Heart Center, Evansville, IN; St. Mary’s Medical Center, Evansville, IN; Deaconess Hospital, Evansville, IN; Greater Baltimore Medical Center, Towson, MD; Humana University Hospital, Louisville, KY.

(1993)

Louis A. Johnson VA Medical Center, Clarksburg, WV; Sentara Bayside Hospital, Virginia Beach, VA; Indiana County Medical Society, Indiana, PA; Cleveland Academy of Osteopathic Medicine, Cleveland, OH; Peninsula Regional Medical Center, Salisbury, MD; University of Chicago School of Medicine, Chicago, IL; Western Missouri Mental Health Center, Kansas City, MO; Mid-Missouri Mental Health Center, Columbia, MO; Missouri Institute of Mental Health, St. Louis, MO; Beckley Appalachian Regional Hospital, Beckley, WV; The Reading Hospital & Medical Center, Reading, PA; University of Cincinnati Medical Center, Cincinnati, OH; Washington Hospital Center, Washington, DC; Wright Patterson Air Force Base, Dayton, OH; Dayton Veterans Hospital, Dayton, OH; University of Cincinnati, Cincinnati, OH; Pali Momi Memorial Hospital, Aiea, HI; Wahiawa General Hospital, Wahiawa, HI; Mississippi Medical Center, Jackson, MS; Bristol Regional Medical Center, Bristol, TN; Marshall University Medical School, Internal Medicine, Huntington, WV; Wisconsin Medical Center, Milwaukee, WI; Cabell Huntington Hospital, Huntington, WV; St. Francis Hospital, Pittsburgh, PA; University of South Alabama Medical Center, Mobile, AL; Mobile Infirmary Medical Center, Mobile, AL; Deaconess Hospital, Evansville, IN; Welborn Baptist Hospital, Evansville, IN; Frick Hospital, Mount Pleasant, PA; Saint Margaret Memorial Hospital, Pittsburgh, PA; Greater Baltimore Medical Center, Towson, MD; Internal Medicine Mid-Island Hospital, Bethpage, NY; Brookdale Hospital, New York, NY; Long Island Heart Council, Williston Park, NY; St. John’s Hospital, Smithtown, NY; Flushing Hospital, Flushing, NY; Pleasant Valley Hospital, Pleasant Valley, WV; Manatee Memorial Hospital, Bradenton, FL; L.W. Blake Memorial Hospital, Bradenton, FL; Moses H. Cone Hospital Family Practice Center, Greensboro, NC; Charleston Area Medical Center, Cancer Care Center, Charleston, WV; Miami Valley Hospital, Department of Obstetrics & Gynecology, Dayton, OH; Dayton Veterans Administration Medical Center, Dayton, OH; West Virginia University School of Medicine, Department of Family Medicine, Morgantown, WV; Clinch Valley Medical Center, Richland, VA; Allegheny General Hospital, Medical College of Pennsylvania, Division of Cardiology, Pittsburgh, PA; Trinity Memorial Hospital, Cudahy, WI; West Florida Regional Medical Center, Pensacola, FL; Halifax Regional Hospital, South Boston, VA; West Virginia University School of Medicine, Department of Internal Medicine, Internal Medicine Residents, Morgantown, WV; Marion County Dental Society, Fairmont, WV; West Virginia University School of Medicine, Department of Pediatrics, Morgantown, WV; Saint Joseph Hospital, Towson, MD; Princeton Community Hospital, Princeton, WV; Belmont County Medical Society, St. Clairsville, OH; St. Joseph’s Hospital, Parkersburg, WV.

(1994)

Department of Obstetrics & Gynecology, West Virginia University School of Medicine, Morgantown, WV; Kimbrough Army Community Hospital, Fort George G. Meade, MD; West Virginia School of Osteopathic Medicine, Lewisburg, WV; Saint Thomas Hospital, Cardiology Department & Cardiac Rehabilitation Department, Nashville, TN; Licking Memorial Hospital, Newark, OH; Good Samaritan Medical Center, Zanesville, OH; Department of Veteran Affairs, Medical Center Chillicothe, Chillicothe, OH; Riverside Methodist Hospital, Columbus, OH; Garrett County Memorial Hospital, Oakland, MD.

(1995)

West Virginia University School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown, WV; Liberty Medical Center, Baltimore, MD; West Virginia University School of Medicine, Hematology-Oncology, Morgantown, WV; Malcom Grow Medical Center, Andrews AFB, MD; Department of Surgery, West Virginia University School of Medicine, Morgantown, WV; MDTV Satellite beamed to 7 hospitals -- (Grant Memorial Hospital, Petersburg; Davis Memorial Hospital, Elkins; St. Joseph Hospital, Buckhannon; CAMC, Charleston; Boone Memorial Hospital, Madison; Braxton County Hospital, Gassaway; Clarksburg Veteran’s Hospital, Clarksburg); Ohio Valley Medical Center, Wheeling, WV; St. Thomas Hospital, Akron, OH; Houston Northwest Medical Center, Houston, TX.

(1996)

Orange County Regional Cancer Center & the Orange County American Cancer Society, Orange County, CA; West Virginia University School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown, WV; Arlington Memorial Hospital, Arlington, TX; Arlington Medical Center, Arlington, TX; The Texas Cancer Center, Arlington, TX; Tri County (Harrison, Mon, Marion) Medical Association, Clarksburg, WV; Bristol Regional Medical Center. Bristol, TN; Department of Behavioral Medicine & Psychiatry, WV School of Medicine, Morgantown, WV; West Virginia University School of Medicine, Hematology/Oncology, Morgantown, WV; East Carolina University School of Medicine, Greenville, NC.

(1997)

Griffin Hospital, Derby, CT; Fountain Valley Regional & Medical Center, Orange County Regional Cancer Center, Orange County, CA; Jackson General Hospital, Ripley, WV; University of Rochester Medical Center, School of Medicine, Rochester, NY; West Virginia University School of Medicine Department of Pediatrics, Adolescent Medicine, Morgantown, WV; Thomas R. Beam, Jr, Memorial Institute for Continuing Medical Education, Northeastern University-Bouve College of Pharmacy, beamed to 78 hospitals; Gaston Memorial Hospital, Charlotte, NC; Jewish Hospital, Shelbyville, KY; Carolina Medical Center, Charlotte, NC; VA Medical Center in Salisbury, Salisbury, NC; Center for Mental Health, Charlotte, NC; Cabarrus County Medical Society, Concord, NC; Physician Services (Formerly Primary One) Charleston, WV; Community Methodist Hospital, Henderson, KY; Bowman Gray School of Medicine, Wake Forest University & NC Baptist Hospital, Cardiology Department, Winston-Salem, NC; Wheeling Hospital, Wheeling, WV; West Virginia University School of Medicine, Department of Family Practice, Morgantown, WV; Huntington Internal Medicine Group, Huntington, WV; St. Mary’s Hospital, Pulmonary & Cardiology, Huntington, WV; St. Francis Hospital, Charleston, WV; Northside Medical Clinic, Jackson, TN; St. Joseph’s Hospital, Parkersburg, WV; Department of Behavioral Medicine & Psychiatry, West Virginia University School of Medicine, Morgantown, WV; Georgetown University Hospital, Washington DC; MDTV Satellite beamed to 15 hospitals in West Virginia; Ireland Army University Hospital, Ft. Knox, KY; Potomac Valley Medical Society, Keyser, WV; Ft. Knox Medical Society, Ft. Knox, KY; Alliant Medical Pavilion, Louisville, KY.

(1998)

North Carolina Regional Hospital & the UNC School of Medicine, Shelbyville, NC; Rutherford Medical Society, Rutherford, NC, West Virginia University School of Medicine, Department of Pediatrics, Morgantown, WV; Fairmont Clinic & Fairmont General Hospital, Fairmont, WV; Lincoln Medical Center, Lincolnton, NC; Davis Memorial Hospital, Elkins, WV; Naval Medical Center, Portsmouth, VA; Ohio County Medical Society, Wheeling, WV; West Virginia University School of Medicine, Radiology/Oncology Group, MBRCC, Morgantown, WV; St. Joseph’s Hospital, Buckhannon, WV; Inova Fairfax Hospital, Department of Medicine, Falls Church, VA; Alliant Medical Pavilion, Louisville, KY; Mount Carmel Medical Center, Columbus, OH.

(1999)

West Virginia University School of Medicine, Section of General Internal Medicine, Morgantown, WV; Alderson Broaddus College, Physician Assistant Program, Philippi, WV; Department of Obstetrics & Gynecology, University of Louisville, School of Medicine, Louisville, KY; Carroll County General Hospital, Westminster, MD.

(2000)

West Virginia University, Mary Babb Randolph Cancer Center, Oncology, Morgantown, WV; INOVA Fairfax Hospital, Fairfax, VA.

(2001)

West Virginia University School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown, WV; Sierra Health Services, Las Vegas, NV.

(2003)

University of California-Chico, Student Health Services, Chico, CA; Garrett County Memorial Hospital, Oakland, MD.

(2005)

West Virginia University School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown, WV.

(2006)

University of Florida Family Practice Clinic, Jacksonville FL; Flagler Family Medicine, St. Augustine, FL; Mayo Clinic, Jacksonville, FL; Family Care Center Arlington, Jacksonville, FL; Garrett County Memorial Hospital, Oakland, MD; Johns Hopkins Health Center, Odenton MD; Sacred Heart Hospital, Cumberland, MD; Western Medical System, Memorial Campus, Cumberland, MD; Adelphia Laboratory Center, Adelphia, MD; Franklin Square Hospital Center, Baltimore, MD; Robinwood Medical Center, Hagerstown, MD.

(2007)

Southern Maryland Medical Center, Cardiac Rehab Unit, Clinton, MD; Holy Cross Hospital, Silver Springs, MD; Doctors Community Hospital, Lanham, MD; Christian Care, Wilmington, DE; Calvert Memorial Hospital, Prince Fredrick, MD; Washington-Aventis Hospital; Takoma Park, MD; Perry Point VA Medical Center, Perry Point, MD; Shore Health Group PC, Oakhurst, NJ; Columbia Medical Center, Columbia, MD; Southern Maryland Medical Center, Clinton, MD; Plumtree Family Health Center, Bel Air, MD; Newark Beth Israel Medical Center, Cardiology Department, Newark, NJ.

(2008)

Kent General Hospital, Dover, DE; Milford Memorial Hospital, Milford, DE; Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem; Monmouth Medical Center, Longbranch, NJ.

(2009)

Internal Medicine Associates, Fort Myers, FL; Internal Medicine of Southwest Florida, Fort Myers, FL.

(2010)

Lee Physician Group, Fort Myers FL, Physicians Regional Medical Center, Naples, FL; Hunt Club Medical, Apopka, FL; Florida Heart Group, Orlando, FL; Family Healthcare, Denton, TX (teleconference); Graham Clinics, Graham, TX (teleconference); Family Practice Associates, Wichita Falls, TX (teleconference); Lake Whitney Physicians Clinics, Whitney, TX (teleconference); Sugarland Family Practice, Sugarland, TX (teleconference); Willowbrook Cardiology Associates, Houston, TX (teleconference); Westport Family Medicine, Fort Worth, TX (teleconference); Baylor Family Medicine, Wylie, TX (teleconference); Brownfield Medical, Brownfield, TX (teleconference); Midtown Family Practice, Houston, TX (teleconference); Cardiac Center of Texas, McKinney, TX (teleconference); Dresher Family Practice, Dresher, PA (teleconference); Colonades, Jackson, MS (teleconference); Craddock Clinic, Sylacaaga, AL (teleconference); Moulton Family Clinic, Moulton, AL (teleconference); Birmingham Internal Medicine Associates, Birmingham AL (teleconference); Family Medicine Center, Columbia, MS (teleconference); St. Dominic’s Internal Medicine Center, Jackson, MS (teleconference); Ninth Street Internal Medicine, Philadelphia, PA (teleconference); Temple Family Practice, Philadelphia, PA (teleconference); Medical Center of Bustleton, Philadelphia, PA (teleconference); Burlington Family Practice, Buckingham, PA (teleconference); Prohealth, Bristol, CT (teleconference); Family Care Practice, Prospect, CT (teleconference); St Vincent’s, Bridgeport, CT (teleconference); Danbury Medical Group, Danbury, CT (teleconference); HealthQuest, Millbrook, NY (teleconference); Norwalk Medical Group, Norwalk, CT (teleconference); WellOne, North Kingston, RI (teleconference); Milford Physicians, Milford, CT (teleconference); Glastonbury Osteopathic, Glastonbury, CT (teleconference); Charter Oak Walk-In, East Lyme, CT (teleconference); Cottage Grove Cardiology, Bloomfield, CT (teleconference); White River Diagnostic Clinic, Betesville AR (teleconference); FirstCare North, Fayetteville, AR (teleconference); Caddo Family Medicine, Shreveport, LA (teleconference); Oak Grove Family Clinic, Hattiesburg, MS (teleconference); Tuscaloosa Internal Medicine, Tuscaloosa, AL (teleconference); Bessemer West, Bessemer, AL (teleconference); Saltillo Clinic, Saltillo, MS (teleconference); Meridian Medical Associates, Meridian, MS (teleconference); Cooper/Haw Clinic, Springdale, AR (teleconference); Greystone Family Clinic, Cabot, AR (teleconference); St. Vincent’s Family Practice, Little Rock, AR (teleconference); First Care Tontitown, Springdale, AR (teleconference); Piechal Medical Clinic, Fayetteville, AR (teleconference); Paragould Family Practice Clinic Paragould, AR (teleconference); Heart Clinic of Arkansas, Searcy, AR (teleconference); Pinnacle Physicians Group, Malvern, AR (teleconference); Valley Medical Arts Clinic, McAllen, TX (teleconference); Campbell Family Practice, Houston, TX (teleconference); Trinity Medical Clinic, Ft Worth, TX (teleconference); Panther Creek Medical Center, The Woodlands, TX; (teleconference); Burleson Family Center, Burleson, TX (teleconference); Clinics of North Texas, Wichita Falls, TX (teleconference); Heart Place, Plano, TX (teleconference); Johnson & Mosley, MD, PC, Jasper, AL (teleconference); Elliot Primary Care at Raymond, Raymond, NH (teleconference); Jefferies Family Practice, Surprise Health Center, Surprise, AZ (teleconference); Seacoast Cardiology, Somersworth, NH (teleconference); Derry Medical Center, Derry, NH (teleconference); Metro Health Hospital, Cleveland, OH (teleconference); NECOS, Akron, OH (teleconference); Good Samaritan Family Medicine, Dayton, OH (teleconference); Flower Hospital, Sylvania, OH (teleconference); Alexican Brothers Medical Group, Hanover Park, IL (teleconference); Physician Group Associates, Springfield, IL (teleconference); Witham Family Practice, Lebanon, IL (teleconference); WPAFB, Dayton, OH (teleconference); Community Physician Group, Belleville, IL (teleconference); The Cardiology Center, Cincinnati, OH (teleconference); DuPage Medical at Central DuPage Hospital, Winfield, IL (teleconference); Berger Health System, Cirderville, OH (teleconference); Toledo Hospital, Toledo, OH (teleconference); University Health Systems, Cleveland, OH (teleconference); Premiere Medical Partners, Cuyahoga Fall, OH (teleconference); Akron Health Department, Akon, OH (teleconference); North Coast Professional Company, Sandusky, OH (teleconference); St Luke Hospital, Maumee, OH (teleconference); St Mary’s Good Samaritan Family Health Center, Centrelia, IL (teleconference); Sansum-Santa Barbara Medical Center, Lompoc Branch, Lompoc, CA (teleconference); Printers Park Medical Plaza, Colorado Springs, CO (teleconference); Beaver Medical Group, Yucaipa, CA (teleconference); Sansum Clinic, Carprinteria, CA (teleconference); Community Health Providers, Fresno, CA (teleconference); Camp Pendelton Naval Hospital, Camp Pendelton, CA; Olive View Medical Center, Sylmar, CA (teleconference); University of Colorado Health Sciences Center, Aurora, CA (teleconference); Mercy Family Practice, Rockford, IA (teleconference)

(2011)

Alton Family Practice, Alton, NH; Wright & Associates Family Care, Amherst, NH; FMC New Tampa, Tampa, FL; Family Medical Center of Tampa Bay, Tampa; Watson Clinic, Lakeland, FL; Family Medical Care, Riverview, FL; Family Practice Center of Plant City, Plant City, FL; Camp Pendelton Naval Hospital, Camp Pendelton, CA; Grossmont Family Practice, La Mesa, CA; Patterson Avenue Family Practice, Richmond, CA;

(2013)

St Matthew Medical School, Grand Cayman, Cayman Islands

Conducted Workshops/In-Service Training In Several Major U.S. Cities (to name a few): Tulsa, Austin, El Paso, Atlanta, Louisville, Kansas City, Denver, Topeka, Brownsville, San Antonio, Houston, Amarillo, Dallas, Oklahoma City, Bethesda, Raleigh, Fayetteville, Nashville, Greensboro, Birmingham, Morgantown, Washington DC, Charlotte, Indianapolis, Columbus, Toledo, Dayton, San Diego, Charleston, Saratoga, Redwood City, Santa Cruz, Pismo Beach, San Jose, Concord, Las Vegas, Huntington, Pittsburgh, West Palm Beach, Cleveland, Oakland, San Francisco, Baltimore, Springfield, Cincinnati, Greenville/Spartanburg, Orlando, Chicago, Palo Alto, Burlingame, Pleasanton, Marina Del Rey, Honolulu, Johnson City, Milwaukee, Mobile, Evansville, New York, Winston-Salem, Minneapolis-St. Paul, Seattle, Bangor, Reno, Colorado Springs, Detroit, St. Louis, New Orleans, Ventura County, Charleston, Hot Springs, Albuquerque, Annapolis, Manchester, NH; Portsmouth, VA; Wilmington, DE; Norfolk, VA, Philadelphia, Chico, CA; Memphis, TN; Rockville, MD; Miami FL; Middletown, CT; New Haven, CT; Providence, RI; Groton, CT; & other U.S. cities.

International Workshops/Seminars: Stockholm (Sweden), Goteborg (Sweden), Sydney (Australia), London (England), Helsingborg (Sweden), Mexico City (Mexico); San Juan (Puerto Rico), Monterrey (Mexico), Guadalajara (Mexico), Puebla (Mexico), Santiago (Chile), Bangkok (Thailand), Manila (Philippines); San Salvador (El Salvador); Tegucigalpa (Honduras); Managua (Nicaragua); San Jose (Costa Rica); Guatemala City (Guatemala); Panama City (Panama); Port of Spain (Trinidad); Nassau (Bahamas); Santo Domingo (Dominican Republic); Mayaguez (Puerto Rico); Ponce (Puerto Rico); San Juan (Puerto Rico); Grand Cayman (British West Indies).

Major Television Appearances: Dr Glover has appeared on many television programs; People, PM Magazine, 20/20, Charlie Rose Show, Town Meeting, Good Morning America, Week Days, C-Span, Health Talk America, Christian Broadcasting Network (CBN), Sunday Magazine, CBS Morning News, D.O.C. (Doctors on Call), Televisa (Mexico City), Medical Discoveries (WCNC-Charlotte), MD TV (San Juan, Puerto Rico), Dateline, Peter Jennings Evening News World Report, CBS News, German Television, Australian Broadcasting Corporation, & numerous other television programs. Moreover, he has appeared on hundreds of radio programs throughout the North America & Europe, among these are “Sunday Rounds” on National Public Radio, “Radio Broadcast News” on ABC News, “Public Affairs Radio” in Canada, Off-Duty America on Dr. Derek DeSilva’s “Ask the Doctor” on National Public Radio, “Radio Programas” de Mexico, “New Broadcast Network,” “World Wide Live,” “CBS National Radio,” & “Washington Post Radio.”

CONSULTING ACTIVITY:

Des Moines ISD, Youth Stop Smoking Programs, 1979

Great American Smokeout, State of Texas, 1979-82

Life & Health, Random House, 3rd Edition, 1980

Kentucky State Board of Education, 1980

Kentucky American Cancer Society, Youth Smoking Cessation, 1980

Ottawa University, Gerontology Program, Ottawa, 1981

American Broadcasting Corporation, Tobacco, 1981-82

Essentials of Life & Health, Random House, 3rd Ed, 1981

Texas Education Agency, Smoking Cessation: 1981-1983

Sul Ross University, Substance Abuse, 1982

Strech-Vaugh Publishers, Health Education Text, 1982-83

Oklahoma State Board of Education, 1983

Ladies Home Journal, Addictive Personality, 1983

Seventeen Magazine, Teenage Smoking, 1983

Weyerhaeuser Inc, Wellness Programs, 1984

Ohio State University, College of Dentistry, Smokeless Tobacco, 1985-86

Marcee Vs U.S. Tobacco, Oklahoma City, 1985-1986

Walt Disney Educational Media, Tobacco, 1985

Health & Human Services, Office of the Inspector General, 1985; 1986; 1992

Centers for Disease Control, 1985; 1986; 1990; 1991; 1992; 1993

Surgeon General’s Office, Smokeless Tobacco, 1985; 1986; 1989; 1990; 1992; 1993; 1994

National Cancer Institute, 1985; 1986; 1991; 1992

Office on Smoking & Health, 1985; 1992;

Time Magazine, Smokeless Tobacco, 1985

Reader’s Digest, 1985; 1987; 1992

The Physician & Sportsmedicine, Smokeless Tobacco, 1985

Public Citizen Health Research Group, Washington DC, 1985

Illinois PTA, Smokeless Tobacco, 1985

University of North Carolina-Greensboro, AIDS, 1986

Pittsburgh Pirates, NY Yankees & the Kansas City Royals, Smokeless Tobacco, 1986

ALA-North Carolina, Youth Smoking Clinics, 1986

Fred Hutchinson Cancer Research Center, Seattle, 1986

“Curtailing the Use of Smokeless Tobacco through 4-H,”

University of California at Berkeley, NCI Grant, School of Public Health, 1986

National Research & Demonstration Center - Arteriosclerosis Bogalusa Study, 1986

Louisiana State University, Departments of Dentistry & Medicine, 1986

North Carolina Health & Human Resources, 1987

Balance Video Productions, 1987-89

American Cancer Society, National Office, New York, 1987

Maine Department of Human Resources, 1987

“Integrating Tobacco Education into the School Systems,”

University of North Carolina, School of Public Health, NCI Grant, 1987

“Multidisciplinary Indicators To Measure the Impact of P.L.99-252 on Decreasing

Smokeless Tobacco Use,” Ohio State University, CDC Grant, 1987-88

“AIDS Prevention: A Practical Approach,” IBT Video Productions, Kansas City, 1987

“Prevalence & Pattern Use of Smokeless Tobacco in Pennsylvania Colleges & Universities,”

West Chester University & East Stroudsburg University, 1987-89

Savvy Magazine, Women & Smokeless Tobacco, 1987

“Smokeless Tobacco Project,” Northern Rockies Cancer Center, Billings, MT, 1987-88

“Integration of Information on AIDS, Smokeless Tobacco, & Suicide into Comprehensive

School Health Education Curricula to Students in K-12,” Education Development Center,

CDC Grant, 1987-88

“Health Risks of Using Smokeless Tobacco,” Auburn University, NIH Grant, 1987

“Smokeless Tobacco: Prevalence & Use Patterns,” West Chester University, NIH, 1988-89

“Smokeless Tobacco & Cardiovascular Disease in 15,000 Adults,” Auburn University,

American Heart Association Grant, 1988

Pennsylvania State Department of Health, Chewing or Dipping - Do You Know The Score?

(pamphlet) 1989

WV State Department of Health, NCI ASSIST Grant, Smokeless Tobacco Cessation, 1989

University of Minnesota, Department of Psychiatry, Medical School, Smokeless Tobacco,

NIDA Grant, 1991

Edelman Public Relations Worldwide, Tobacco Cessation, Nicorette/Nicoderm, 1991-96

United States Marine Recruiting Depot, Smokeless Tobacco, San Diego, 1991

Medical Information Services, Consulting Medical Editor, New York, 1991-98

Member, Advisory Committee in Smoking Cessation, Ted Klein & Company, New York,

1992-94

“Spitting Tobacco-Free Baseball,” University of Arkansas for Medical Sciences Grant

National Center for Nursing Research Grant, NIH, 1993

“Snuffing Out Tobacco -- A Teleconference,” A two-hour teleconference on tobacco,

beamed throughout the United States from West Virginia University School of Medicine,

May, 1993

“Is There a Safe Cigarette?” BBC-TV, Watch Dog, London, England, July, 1993

Member, Consensus Committee, Combination Nicotine Replacement Therapy Workshop, Paris, France, Nov, 1993

“Study to Determine the Maximum Tolerated Dose & Frequency of Administration of

NicErase-SL in Sequestered Normal, Healthy Men & Women Who Are Cigarette Smokers & Are Required to Stop Smoking Abruptly,” DynaGen Ft. Meyers, FL, Jan, 1994

Porter-Novelli, Public Relations Firm, New York, Nicorette 2mg & 4mg, 1994-96

International Medical News Group, Rockville, MD, Oral Inhaler, Nasal Spray, 1994

Proctor & Gamble, Tobacco Control, 1994-98

Good Housekeeping Magazine, Smoking Cessation Aids, 1994

Expert Witness, Samsel v. Lederle Laboratories, U.S.D.C. M.D. Pa/ No. 94-0447, 1994

Wall Street Journal, Smokeless Tobacco, 1994

The Hazelden Report, Smokeless Tobacco, 1994

McNeil Consumer Products Company, Tobacco, 1994

Nelson Company, Inc, Tobacco, 1994

Excerpta Medical, Tobacco, 1994

Egyptian Embassy, Tobacco, 1995

State of Nebraska, Behavioral Review Panel for the Nebraska Cancer & Smoking Disease Program Grants, 1995

Clinical Consultant, University of Pittsburgh Medical Center, Smoking Cessation, 1995

Agency for Health Care Policy & Research (AHCPR), Smoking Prevention & Cessation Clinical

Practice Guidelines, Public Health Services, Department of Health & Human Services, 1995

The Center for Corporate Health, Taking Care Program, Oct, 1995

Arizona Department of Health Services, Grant Reviewer, for RFP H6-004 (Tobacco Education & Prevention), Dec 1995

National Cancer Institute of Canada, Scientific Peer Review Committee, Research Applications for Tobacco Grant Support, 1996

Home Box Office (HB0) & Consumer Reports - Joint HBO Television Program on Tobacco, 1996

Editorial Advisory Board, “Pharmacy Practice Guidelines for the OTC Era” 1996

America On Line, Developing a Tobacco Web site for Parents, 1996

Rodel Press, Smoking Cessation & Weight Control, 1996

SmithKline Beecham, Nicotine Sublingual Tablet & NRT, 1996

Pennsylvania Blue Cross Blue Shield, Smoking Cessation, 1997

Healthcare Advisory Board, Washington DC, Tobacco, 1997

Carolina Medical Center, Charlotte, NC 1997

Nicotine Dependency Center, Cabarrus County, NC, 1997

Department of Family & Community Medicine, The Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC, 1997

Research Testing Laboratories, Inc., Clinical Testing Specialists, Great Neck, NY, 1997

American Journal, CBS Television Programming, 1997

Emergency Medicine Magazine, Bupropion, 1998

Hendrickson & Long Attorneys at Law. McCune v. The American Tobacco Co., et al.,

1998-2000 (Expert Witness)

The University of New Mexico, Health Sciences Center, Cancer Research & Treatment

Center, Epidemiology & Cancer Control, Southwest Smokeless Tobacco Youth Cessation

Project, 1998

International Medical News Group, Rockville, MD, Smoking Cessation Drug Therapies, 1998

Air Line Pilots Association, Singapore, Stress & Physical Performance in the Cockpit for Pilots Attempting to Quit Smoking, 1998

Money Magazine, Update on the Latest Smoking Cessation Strategies, 1998

SDM, Inc., Smoking Cessation Products, 1999

The British Broadcasting Corporation (BBC), Bupropion SR, 1999

Humphrey, Farrington & McClain, P.C. West Virginia Mass Litigation Panel-Civil Action No. 00-C-5000 (Individual Personal Injury Cases) (Expert Witness), 2000-2005

Defined Health, Smoking Cessation Product Development, 2000

In re: Tobacco Litigation (Medical Monitoring Cases), Civil Action No. 00-C-6000 (Cir. Ct. of Ohio County, West Virginia), 2000

Missouri Institute of Mental Health, NCI Smoking Grant, 2000-2002

Krog & Partners Inc., Smoking Cessation, 2001

Medical Decision Logic, Inc. “Peer Interactions & Adolescent Tobacco Use” SBIR Grant, Tien AY, PI, 2001

Partners in Corporate in Health Inc. Establishing a training program for the treatment of nicotine dependence in rural counties, 2001.

The Health Services Group of American, Richmond, VA. Implementing Start START.

Blue Cross Blue Shield of Western Pennsylvania, Pittsburgh, PA. Evaluating the implementation of Start SMART, 2001.

Garrett County Health Department, Oakland MD. Effective treatments for nicotine dependence, 2002.

National Cancer Institute (NCI) Tobacco Control Research Branch, Rockville MD. Clinical trial development to develop NCIs Tobacco Intervention Research Clinic, 2002.

Strategic Analysis Inc., Protocol Development, 2003

External Advisory Board Member, “Tobacco Use & Cessation” 5-Year NCI RO1, Ohio State University, Columbus, OH, 2003-2008

Newsweek Magazine, Treatments for Obesity, 2004

Garrett County Health Department, Oakland MD. Update: Treatments for nicotine dependence, 2006

Macro International, Smoking Cessation, 2006

Macro International, Smokeless Tobacco Cessation, 2007

Commissioner for Academic Accreditation, Ministry of Higher Education and Scientific Research, United Arab Emirates, MPH Accreditation for the Gulf Medical University, 2009.

Cayman Cancer Society, Cayman Public Health, Ministry of Home Affairs Cayman Islands, Education, Training & Consulting, Cayman Island (British West Indies), 2013

Planning Committee Member, 7th Winter Meeting Health, Environment and Education – Equity for the Planet, Koln, Germany, 2013

PROFESSIONAL PAPERS & PRESENTATIONS:

(International)

1981 “Psychological Satisfactions of Smoking Reported by 57 Habituated Dental Patients”

59th International Association for Dental Research, Chicago, IL (AG Christen, ED Glover)

1983 “Smokeless Tobacco: A Merging Concern”

5th World Conference on Smoking & Health, Winnipeg, Canada (ED Glover, SW

Edwards, AG Christen)

1985 “Smokeless Tobacco Use Trends in the US Among College Students”

12th World Conference on Health Education, Dublin, Ireland (ED Glover, R Johnson, M Laflin, SW Edwards, AG Christen)

1986 “A Statewide Study of Prevalence, Intentionality & Age of Initiation of Smokeless Tobacco in the United States”

WHO-Preventa International Congress on Community-Based Prevention & Health Promotion, Dusseldorf, Germany (ED Glover, KL Schroeder)

1986 “Oral Soft Tissue Changes & Characteristics of Smokeless Tobacco Users from a University Dental Clinic Population”

World Dental Conference, Jerusalem, Israel (KL Schroeder, MS Chen, ED Glover)

1987 “Smokers & Smokeless Tobacco Users: Comparing Personality Traits”

5th International Congress of the World Federation of Public Health Associations, Mexico City, Mexico (ED Glover, EW Edmundson, PP Alston, D Holbert, DM White)

1988 “Confounding Variables & Intentionality in Longitudinal Smokeless Tobacco Screening & Interaction Studies”

66th International Association for Dental Research, Montreal, Canada (KL Schroeder, ACG Milo, MS Chen, ED Glover)

1989 “Comparative Effects of Smokeless Tobacco & Cigarettes on Cardiovascular Dynamics”

67th International Association for Dental Research, Dublin, Ireland (ED Glover, KL Schroeder, CJ Neal, MS Chen)

1989 “Development of Health Education in North America”

National Association of Health Education Officers, Sligo, Ireland (Invited)

1989 “Acute Effects of Moist Snuff During Submaximal Exercise”

50th Finnish Society of Sports Medicine, Paavo Nurmi Congress Turku, Finland (ED Glover, D Flannery, KL Schroeder)

1989 “Comparison Snuff & Cigarettes on Cardiovascular Hemodynamics in Young Adults”

50th Finnish Society of Sports Medicine, Paavo Nurmi Congress Turku, Finland (ED Glover, KL Schroeder)

1989 “Tobacco & Periodontal Health”

Karolinska Institute, Huddinge, Sweden (Invited)

1989 “Smokeless Tobacco Cessation: Implications for Oral Health”

University of Gothenburg, Sweden (Invited)

1990 “Cardiovascular Responses to Snuff”

14th Commonwealth & International Conference on Physical Education, Sport, Health & Dance, Auckland, New Zealand (ED Glover, RW St. Pierre, D Flannery)

1990 “The Impact of a 21-Year Drinking Age Law on University Students”

14th Commonwealth & International Conference on Physical Education, Sport, Health & Dance, Auckland, New Zealand (JL Lotterhos, ED Glover, D Holbert)

1990 “Comparison of Snuff & Cigarettes on Cardiovascular Hemodynamics in Young Adults”

7th World Conference on Tobacco & Health, Perth, Australia (ED Glover, KL Schroeder, LL Borchers)

1990 “Smokeless Tobacco & the Athlete”

Cronulla Family & Sports Medicine Centre, Cronulla, Australia (Invited)

1991 “The North American Problem - Risk Groups for Smokeless Tobacco Use”

1st International Conference on Smokeless Tobacco, Columbus, OH (Invited)

1991 “Cessation & Smokeless Tobacco”

1st International Conference on Smokeless Tobacco, Columbus, OH (Invited)

1991 “Nicotine Exposure & Cardiovascular Effects with Smokeless Tobacco”

1st International Conference on Smokeless Tobacco, Columbus, OH (KL Schroeder, CJ Neal, ED Glover, MS Chen) (Invited)

1991 “Utilizing Nicotine Reduction Therapy”

Kabi Pharmacia, Helsingborg, Sweden (Invited)

1991 “Leukoplakia & Smokeless Tobacco Keratosis are Two Separate Cancers”

2nd International Congress on Oral Cancer, Bombay, India (J Bouquot, ED Glover, KL Schroeder)

1992 “Preliminary Results of the Nicotine Oral Inhaler for Smoking Cessation”

Smoking Cessation Scientific Meeting, Herfordshire, England (Invited)

1992 “The Safety & Efficacy of Nicorette 4mg as a Smoking Cessation Aid for Highly Dependent Smokers”

8th World Conference on Tobacco or Health, Buenos Aires, Argentina (ED Glover, D Daughton, WJ Huster, RT Nowak, OF Pomerleau, SI Rennard, CN Rolf, DPL Sachs, ML Stitzer, W Wadland)

1992 “Nicotine Inhaler Versus Placebo in Smoking Cessation”

8th World Conference on Tobacco or Health, Buenos Aires, Argentina (ED Glover, PN Glover, CR Sullivan, P Sullivan, F Nilsson, U Sawe)

1992 “Clinical Efficacy & Safety of Nicoderm (Nicotine Transdermal System; NTS) for Smoking Cessation”

8th World Conference on Tobacco or Health, Buenos Aires, Argentina (ED Glover, D Causey, CN Rolf, the Transdermal Nicotine Study Group)

1992 “The Safety & Efficacy of a Nicotine Transdermal System (NTS) for Smoking Cessation”

2nd International Congress on Behavioral Medicine, Hamburg, Germany (ED Glover, The Transdermal Nicotine Study Group)

1992 “The Safety & Efficacy of Nicorette 4mg as a Smoking Cessation Aid for Highly Dependent Smokers”

2nd International Congress on Behavioral Medicine, Hamburg, Germany (ED Glover, OF Pomerleau, SI Rennard, DPL Sachs, ML Stitzer, W Wadland)

1992 “Smoking Cessation & Transdermal Patches”

United States Air Force Worldwide Health Promotion Conference, Washington, DC (Invited)

1993 “Pharmacokinetics & Design of the American Nicotine Transdermal Patches”

Institute of Psychiatry, Health Behaviour Unit, London, England (Invited)

1994 “The Efficacy of Free Distribution of Nicotine Transdermal Patches”

9th World Conference on Tobacco & Health, Paris, France (RH Anderson, WT Wallace, ED Glover)

1994 “An Open Phase III Pilot Clinical Trial in Smoking Cessation/Prevention with a Nicotine Nasal Spray (NNS)”

9th World Conference on Tobacco & Health, Paris, France (ED Glover, PN Glover, M Franzon, A Westin)

1994 “Start SMART - A Pharmacologic & Behavioral Approach to Smoking Cessation”

9th World Conference on Tobacco & Health, Paris, France (PN Glover, ED Glover, D Flannery)

1995 “The Latest Cigarette Cessation Strategies”

Dia Muncial Sin Fumar, Secretaria de Salud, Instituo Nacional de Enfermedades Respiratorias, Mexico City, Mexico (Invited)

1996 “A Multi-Center Phase 3 Study of NicErase-SL for Smoking Cessation”

4th International Congress of Behavioral Medicine, Washington DC (ED Glover, SJ Leischow, SI Rennard, PN Glover, D Daughton, J Quiring)

1996 “A Pilot Phase 3 Study of Lobeline Sulfate for Smoking Cessation”

12th International Conference on Pharmacoepidemiology, Amsterdam, The Netherlands (ED Glover, SJ Leischow, SI Rennard, PN Glover, D Daughton, J Quiring)

1997 “A Nicotine Sublingual Tablet for Smoking Cessation: 6-Month Data”

10th World Conference on Tobacco or Health, Beijing, China (ED Glover, PN Glover, M Franzon, CR Sullivan, PM Sullivan, R Howell, G Keyes)

1997 “A Double-Blind, Placebo-Controlled Trial for Smoking Cessation with Bupropion”

10th World Conference on Tobacco or Health, Beijing, China (RD Hurt, DPL Sachs, ED Glover, KP Offord, PN Glover, CR Sullivan, PM Sullivan)

1998 “Bupropion SR for Smoking Cessation: A Placebo-Controlled Trial”

XXIst Collegium Internationale Neuro-Psycholpharmacologicum, Glasgow, Scotland (ED Glover, DPL Sachs, JA Johnston, PN Glover, CR Sullivan, PM Sullivan, CL Cerullo)

1998 “The Effect of Bupropion SR on Craving in Tobacco Dependence”

XXIst Collegium Internationale Neuro-Psycholpharmacologicum, Glasgow, Scotland (T Grasela, ED Glover, DPL Sachs, JA Johnston)

1998 “Smoking Cessation with Sustained Release Bupropion”

First International Conference of The Society for Research on Nicotine & Tobacco

(SRNT), World Health Organization (WHO), International Council on Alcohol &

Addictions (ICAA), The European Medical Association on Smoking & Health

(EMASH), Copenhagen, Denmark (ED Glover, RD Hurt, DPL Sachs, KP Offord, JA

Johnston, PN Glover, CL Cerullo)

1998 “Bupropion SR for Smoking Cessation: Predictors of Successful Outcome”

First International Conference of The Society for Research on Nicotine & Tobacco

(SRNT), World Health Organization (WHO), International Council on Alcohol &

Addictions (ICAA), The European Medical Association on Smoking & Health (EMASH), Copenhagen, Denmark (RD Hurt, LC Dale, DR Schroeder, DPL Sachs, ED Glover)

1998 “Advances in the Management of Smoking Cessation”

Mexico Conference, Simposio Advances En El Manejo De La Epoc (Advances in COPD Management), Miami, FL (Invited)

1999 “Bupropion SR Vs Placebo for Smoking Cessation”

Smoke Free 21st Century, 2nd European Conference on Tobacco or Health, 1st

Iberoamerican Conference on Tobacco or Health, Las Palmas de Gran Canaria, Canary Islands, Spain (ED Glover, RD Hurt, DPL Sachs, JA Johnston, PN Glover, CR Sullivan, PM Sullivan, CL Cerullo)

1999 “Safety & Efficacy of a Nicotine Sublingual Tablet for Smoking Cessation: 6-Month

Follow-up”

Smoke Free 21st Century, 2nd European Conference on Tobacco or Health, 1st

Iberoamerican Conference on Tobacco or Health, Las Palmas de Gran Canaria, Canary Islands, Spain (ED Glover, PN Glover, M Franzon, CR Sullivan, CL Cerullo, RM Howell, PM Sullivan, GG Keyes, F Nilsson, GR Hobbs)

1999 “Lobeline Sulfate for Smoking Cessation: A Multi-Center Trial”

Smoke Free 21st Century, 2nd European Conference on Tobacco or Health, 1st

Iberoamerican Conference on Tobacco or Health, Las Palmas de Gran Canaria, Canary Islands, Spain (ED Glover, PN Glover, CL Cerullo, P Tonnesen, L Repsher, J Quiring)

1999 “Treating Tobacco Addiction—Nicotine or No Nicotine?”

Simposio Neurotransmisores y Enfermedad (Neurotransmitters & Disease), Mexico City, Mexico (Invited)

1999 “The Nicotine Addiction & The Latest Treatments”

Celbracion Dia Mundial Sin Fumar, Ministerio de Salud, World Health Organization, Santiago, Chile (Invited)

1999 “Aspectos Farmcologicos de la Dependencia a la Nicotina”

Aspectos Psicofarmacologicos de la Nicotina, Santiago, Chile (Invited)

1999 “The US Experience with Zyban for Smoking Cessation”

1st Respiratory Forum for Smoking Cessation, Bangkok, Thailand (Invited)

2000 “The Role of Bupropion in Treating Nicotine Dependent Smokers”

Respiratory Forum for Smoking Cessation, Manila, Philippines (Invited)

2000 “Establishing a Smoking Cessation Clinic”

Respiratory Forum for Smoking Cessation, Manila, Philippines (PN Glover & ED Glover) (Invited)

2000 “Treating the Nicotine Dependent Patient: The Role of the Pharmacological Adjunct”

30th Annual Convention of the Philippine College of Physicians, Manila, Philippines (Invited)

2000 “A Multicenter Evaluation of the Effects of Bupropion Hydrochloride Sustained Release Tablets (BUR SR) Vs Placebo in a Population of Smokers with Chronic Obstructive Pulmonary Disease (COPD)”

World Congress on Lung Health & 10th ERS Annual Congress, Florence, Italy (DP Tashkin, RE Kanner, WC Bailey, AS Buist, PJ Anderson, R Sussman, MK Patel, BD Jamerson, Zyban/COPD Smoking Cessation Trial Group)

2000 “Efficacy & Tolerability of Bupropion Sustained-Release for Smoking Cessation:

A Review of Pivotal Studies”

XXII Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Brussels, Belgium (ED Glover, VL Tucker)

2000 “The Role of Antidepressants in the Treatment of Addictive Behaviors”

XXII Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Brussels, Belgium. Presented & Chaired at a Symposia titled, “The Neurobiology of Depression & Addiction” ED Glover, P Willner, J Rush, D Balfour) (Invited)

2000 “Efficacy of Bupropion SR for Smokeless Tobacco Cessation: Preliminary Data”

11th World Conference on Tobacco OR Health, Chicago, Illinois (ED Glover, J Whoolery, G Hobbs, CL Cerullo, PN Glover)

2000 “Bupropion Hydrochloride Sustained Release Tablets (BUP SR) is Associated with Reduced Weight Gain During Quitting Smoking: Aggregated Analyses of BUP SR Vs Placebo in Quitters Vs Nonquitters”

11th World Conference on Tobacco OR Health, Chicago, Illinois, USA (R Westlund, BD Jamerson, ED Glover, D Davis)

2000 “The Efficacy of Nicotine Patches in Heavy Smokers”

11th World Conference on Tobacco OR Health, Chicago, Illinois (S Shiffman, J Gorsline, J Rohay & Transdermal Nicotine Study Group)

2000 “Health Risks Associated with Smokeless Tobacco Use”

2nd International Conference on Smokeless/Spit Tobacco, Chicago, Illinois (Invited)

2001 “Development of the Glover-Nilsson Behavioral Questionnaire”

European Meeting of the Society for Research on Nicotine & Tobacco, Paris, France

(ED Glover, F Nilsson, A Westin, PN Glover)

2001 “A Nicotine Sublingual Tablet for Treating Tobacco Dependence”

European Meeting of the Society for Research on Nicotine & Tobacco, Paris, France (ED Glover, PN Glover, M Franzon, CR Sullivan, CL Cerullo)

2001 “Efficacy of the Nicotine Inhaler in Smoking Reduction”

European Meeting of the Society for Research on Nicotine & Tobacco, Paris, France (SI Rennard, ED Glover, S Leischow, D Daughton, PN Glover, M Muramoto, T Danielsson, B Landfeldt, A Westin, M Franzon, U Sawe)

2001 “Understanding the Treatment of Nicotine Dependence”

XV Central American Psychiatry Congress, San Salvador, El Salvador (Invited)

2001 “Efficacy & Tolerability of Bupropion SR for Smoking Cessation”

7th World Congress of Biological Psychiatry, Berlin, Germany

2002 “Working with Nicotine Addicted Smokers’

4th Congresso Nacional de Neumologia y Cirugia del Torax Associacion Hondurena de Neumologia, Tegucigalpa, Honduras (Invited)

2002 “Pharmacotherapy for Smokeless Tobacco”

3rd International Conference on Smokeless Tobacco, Stockholm, Sweden (Invited)

2002 “Remifentanil Vs. Methohexital for Electroconvulsive Therapy”

International Conference on Mood Disorders, Monte Carlo (PM Sullivan, E Sinz, G Hobbs, ED Glover, J Cain, A Kofke)

2004 “Rimonabant Achieves Smoking Cessation Without Weight Gain: The STRATUS-US

Study”

13th European Congress on Obesity, Prague, Czech Republic (L Dale, R Anthenelli, ED Glover)

2004 “Using a Cannabinoid Receptor Antagonist as an Aid to Smoking Cessation: STRATUS US”

The Metabolic Syndrome, Type II Diabetes & Atherosclerosis Meeting, Marrakech, Morocco (STRATUS-US Study Investigators)

2004 “Rimonabant Helps Smokers to Quit & Markedly Reduces Post-Cessation Weight Gain: Results from the Status-US Trial” European Society for Nicotine & Tobacco Research, Tübingen, Germany (RM Anthenelli, LC Dale, ED Glover)

2005 “Treating Nicotine Dependence in the USA”

Tobacco Prevention Group, Karolinska Institute, Department of Public Health, Stockholm, Sweden (Invited)

2005 “Glover-Nilsson Smoking Behavioral Questionnaire in Clinical Practice”

5th National Conference on Tobacco Use Prevention & Treatment, Salamanca, Spain (Invited)

2007 “The Effect of Nicotine Dependence Level on Quit Outcomes with Varenicline: Results from a Pooled-Analysis of Three Controlled Trials”

4th European Conference Tobacco or Health 2007, Association of European Cancer League in cooperation with the Swiss Cancer League and the German Cancer Society, Basel, Switzerland (S Swartz, D Gonzales, ED Glover, CB Billing Jr, Williams K)

2009 “Assessment of Nicotine Dependence and It’s Demographic Correlates among African American Smokers’

Combination Meeting of the Society for Research on Nicotine & Tobacco Both US and Europe, Dublin, Ireland (E Sharma, DE Howard, JM Rath, PI Clark, ED Glover)

2009 “Evaluation of Selegiline Transdermal System for Smoking Cessation: Preliminary Results of NIDA’s 246 Subject, Multi-Site Trial”

Combination Meeting of the Society for Research on Nicotine & Tobacco Both US and Europe, Dublin, Ireland (ED Glover)

2009 “Developing Public Health Strategies for Smoking Cessation”

The Health Economics Research for Evaluation in Luxembourg and the Ministry of Health, Luxembourg (Invited)

2010 “Treating Today’s Smokers”

Cayman Cancer Society, Cayman Islands (Invited)

2011 “Achieving and Sustaining Tobacco-Free Behavior for Personal and Social Environments”

5th International Consortium for Interdisciplinary Education About Health and the Environment, University of Cologne, Cologne, Germany (Invited)

2012 “Association Between Cigarette Smoking and the Vaginal Microbiota”

International Human Microbiome Congress, Paris, France, March. (Brothman RM, Ravel J, Gajer P, Koenig SSK, Monogodin EF, Glover ED, Rath JM)

2012 “Reducing Contaminants in Environmental Tobacco Smoke”

6th International Consortium for Interdisciplinary Education About Health and the Environment, University of Cologne, Cologne, Germany (Invited)

2013 “Biomarkers of Cigarette Smoking and Association with the Vaginal Microbiota”

STI and AIDS World Congress, Vienna, Austria, July. (Brothman RM, Ravel J, Gajer P, He X, Fadrosh D, Monogodin EF, Glover ED, Rath JM)

2013 “How to Assist Inmates with Quitting Smoking”

Grand Cayman, British West Indies, (Invited)

2014 Delivered 10 lectures at Tongji Medical University in Wuhan and Three Gorges University Medical School in Yichang on publishing in professional journals and reviewing the latest technology to help smokers with smoking cessation (Invited)

(National)

1977 “Influencing Cigarette Smoking Through Subliminal Perception”

92nd American Alliance for Health Physical Education Recreation & Dance (AAHPERD), Seattle, WA

1977 “Prevention Through Education: The Key to a Non-Smoking Society”

National Commission on Smoking & Public Policy, St. Louis, MO

1977 “The Development, Implementation & Evaluation of a Smoking & Health

Course”

51st American School Health Association (ASHA), Atlanta, GA (ED Glover, R Allen)

1978 “Competency-Based Education”

52nd Meeting, Society of State Directors, Kansas City, MO

1978 “Experiencing Death & Dying”

52nd ASHA, Dearborn, MI

1978 “Mind Control Subliminal Stimulation”

Science Pioneers, Midwest Research Institute, Kansas City, MO

1979 “Living With Cancer”

53rd ASHA, San Diego, CA

1979 “The Prediction of Probable Susceptibility to a Subliminal Stimulation Strategy for Smoking Behavior Modification”

53rd ASHA, San Diego, CA (ED Glover, A Dunleavy)

1980 “Where Do We Align Ourselves?”

54th ASHA, Dallas, TX

1980 “Confronting the Aging Process: An Experiential Approach”

54th Convention, ASHA, Dallas, TX

1981 “Role of Health Beliefs & Social-Psychological Perceptions in Adolescent Smoking Decisions”

96th AAHPERD, Boston, MA (ED Glover, AH Henderson)

1982 “Survey of Health Knowledge Among Texas College Freshmen”

56th ASHA, Phoenix, AZ (ED Glover, AH Henderson)

1984 “The Physiological, Psychological, Behavioral & Health Consequences of Smokeless Tobacco”

58th ASHA, Pittsburgh, PA (ED Glover, V Cleaver)

1985 “Smokeless Tobacco Usage Among School Aged Population”

Testimony, Commonwealth of Massachusetts, Boston, MA

1985 “The Acute Effects of Smokeless Tobacco on Heart Rate & Motor Performance”

6th Society of Behavioral Medicine, New Orleans, LA (ED Glover, SW Edwards, PA Finnicum, GR Bowyer)

1985 “Patterns of Use & Incidence of Smokeless Tobacco Consumption in School-Age Children”

5th Joint Meeting, American Society Head & Neck Surgery & the Society of Head & Neck Surgeons, Puerto Rico (SD Schaefer, AH Henderson, ED Glover, AG Christen)

1985 “Health Hazards of Smokeless Tobacco”

99th Congress, House of Representatives, Committee on Health & the Environment, Testimony on H.R. 2950 & H.R. 3078, Washington DC (Invited)

1985 “A Life Skills Approach to Aging Education”

59th ASHA, Little Rock, AR (ED Glover, J Eddy, K Doyle, M Laflin, M Morrow, MR Eckman)

1986 “Regional Prevalence & Patterns of Smokeless Tobacco Use”

Consensus Development Conference, Sponsored by the National Cancer Institute, the National Institute of Dental Research, & the Office of Medical Applications, National Institutes of Health (Invited)

1986 “Prevalence, Intentionality & Age of Initiation of Smokeless Tobacco Use”

7th Society of Behavioral Medicine, San Francisco, CA

1986 “Prevalence of Smokeless Tobacco Use in Pitt County, North Carolina”

101st AAHPERD, Cincinnati, OH (ED Glover, K O’Brien, D Holbert)

1986 “Personality Differences of Smokeless Tobacco Users & Nonusers”

114th American Public Health Association (APHA), Las Vegas, NV (ED Glover, EW Edmundson, PP Alston, D Holbert)

1986 “Characteristics of Smokeless Tobacco Users from a University Dental Clinic Population”

49th American Association for Public Health Dentistry, Miami, FL (KL Schroeder, ED Glover, MS Chen Jr, EW Edmundson)

1986 “Personality Profiles Associated with Dippers, Chewers & Non-users of Smokeless Tobacco”

60th ASHA, Denver, CO (ED Glover, EW Edmundson, PP Alston, D Holbert)

1986 “Have Our Youth Bitten Off More Than They Can Chew The Growing Problem

of Smokeless Tobacco”

60th ASHA, Denver, CO (ED Glover, C Backinger, LG Scott)

1986 “Prevalence & Patterns of Smokeless Tobacco Use in a College Population”

49th American Association for Public Health Dentistry, Miami, FL (ED Glover, EW Edmundson, KL Schroeder)

1987 “Anatomy of Smokeless Tobacco”

8th Society of Behavioral Medicine, Washington DC (ED Glover, DM Winn, KL Schroeder, SM Hunter) 3-hour presentation

1987 “Smokeless Tobacco Prevention: Psychological Assessment Considerations”

4th Association of Teachers of Preventive Medicine & American College of Preventive Medicine, Atlanta, GA

1987 “Comparing Personality Characteristics of Current & Ex-Smokeless Tobacco Users”

102nd AAHPERD, Las Vegas, NV (ED Glover, EW Edmundson, D Holbert, PP Alston, DM White)

1987 “Alcohol/Drug Abuse Use Patterns of College Students”

102nd AAHPERD, Las Vegas, NV (JF Lotterhos, ED Glover, D Holbert)

1987 “Community Action Against Smoking”

Annual American Medical Association Auxiliary, Chicago, IL (ED Glover, J Coughlin)

1988 “P.L. 99-252: Its Implications for Public Education”

Conference on Multidisciplinary Indicators to Measure the Impact of P.L.99-252 on Decreasing Smokeless Tobacco Use, Columbus, OH (Invited)

1988 “Health Consequences of Smokeless Tobacco & Implications for Educators”

103rd AAHPERD, Kansas City, MO (ED Glover, J Bonaguro, RJ McDermott, PJ Marty)

1988 “Resurrection of the Critical Incident Technique for Aging & Death Education in the Public Schools”

61st ASHA, Lake Buena Vista, FL (ED Glover, M Rose-Colley, B Cinelli)

1988 “Suicide Education: Program Development for High School Curricula”

61st ASHA, Lake Buena Vista, FL (M Rose-Colley, B Cinelli, ED Glover)

1988 “The Impact of the North Carolina 21-Year Drinking Age Law on Underage University Students”

39th National Conference on Alcohol & Drug Problems, Charlotte, NC (JF Lotterhos, ED Glover, D Holbert)

1988 “The Impact of a New 21-Year Drinking Age Law on University Student’s Alcohol/Drug Use”

116th APHA, Boston, MA (JF Lotterhos, ED Glover, D Holbert)

1988 “Prevalence & Patterns of Smokeless Tobacco Use on Pennsylvania Colleges & Universities”

116th APHA, Boston, MA (B Cinelli, M Rose-Colley, ED Glover)

1989 “Relapse Prevention & Health Determinants”

104th AAHPERD, Boston, MA (ED Glover, JM Eddy)

1989 “The Impact of a 21-Year Drinking Age Law on the Alcohol/Drug Use Behavior of College Students”

National Council on Alcoholism: Scientific Forum “89, Atlanta, GA (JL Lotterhos, ED Glover, D Holbert)

1989 “Cardiovascular Responses to Moist Snuff During Exercise”

National Conference on High Blood Pressure Control, Buena-Vista, FL (ED Glover, D Flannery)

1989 “A Smokeless Tobacco Cessation Program for High School Students”

63rd ASHA, Chicago, IL (ED Glover, RD Corcoran)

1989 “A Smokeless Tobacco Cessation Program for High Schoolers”

117th APHA, Chicago, IL (ED Glover, RD Corcoran, M Wang)

1989 “Prevalence of Alcohol Consumption & Recreational Boating in Beaufort County, North Carolina”

117th APHA, Chicago, IL (ED Glover, S Lane)

1990 “Educational Efforts to Curtail Smokeless Tobacco Use Among American Indian Youth”

22nd National Indian Education Association, San Diego, CA (D Flannery, ED Glover)

1991 “Reported Health Problems of Smokeless Tobacco Use Among College Males”

106th AAHPERD, San Francisco, CA (ED Glover, D Flannery, M Wang, D Holbert)

1991 “Publishing in Health Education”

106th AAHPERD, San Francisco, CA (Invited)

1991 “The Publishing Business In Health Education”

Northern California SOPHE, San Francisco, CA (Invited)

1991 “Effects of Nicoderm on Nicotine Withdrawal Symptoms & Smoking Cessation”

Nicotine Reduction Therapy Conference, Marco Island, FL (Invited)

1991 “Effects of a Cessation Program on Smokeless Tobacco Use Among an Adolescent

Population”

119th APHA, Atlanta, GA (ED Glover, PJ Marty, RJ McDermott)

1992 “Treating the Addicted Smoker”

16th Annual Conference on Alcoholism & Drug Abuse, El Paso, TX (Invited)

1992 “Adequate Nicorette 4mg Dosage is Necessary to Manage Tobacco Withdrawal Symptoms in Highly Dependent Smokers”

13th Society of Behavioral Medicine Meeting, New York, NY (ED Glover, W Wadland, ML Stitzer, DPL Sachs, SI Rennard, D Daughton, OF Pomerleau, WJ Huster, RT Nowak, CN Rolf)

1992 “Clinical Efficacy & Safety of a Nicotine Oral Inhaler”

13th Society of Behavioral Medicine Meeting, New York, NY (ED Glover, PN Glover, F Nilsson, U Sawe)

1992 “Transdermal Nicotine for Smoking Cessation”

American Psychiatric Association, Washington DC (JR Hughes, Transdermal Nicotine Study Group)

1992 “Efficacy of a Transdermal Nicotine System for Smoking Cessation”

13th Society of Behavioral Medicine, New York, NY (D Hatsukami, Transdermal Nicotine Study Group)

1992 “What Strategies are Most Effective in ST Cessation?”

Expert Advisory Group on the Essentials of Spitting Tobacco Prevention & Cessation Programs, National Cancer Institute, Rockville, MD (Invited)

1992 “The Role of Nicotine & Tobacco Use: Treatment & Implications”

16th Annual Congress & National Nursing Symposium, Society of Otorhinolaryngology & Head-Neck Nurses, Inc., Washington, DC (Invited)

1992 “The Future of Smoking Cessation”

Annual Meeting of the Air Force Surgeon General’s Office, Washington, DC (Invited)

1992 “Nicotine Transdermal Systems: Technical Design & Mechanism. How Do They Work?”

Special Symposium, “Treatment of Hard Core, High-Risk Smokers Using FDA-Approved Pharmaceutical Agents: An Oral Health Perspective,” Indianapolis, IN (Invited)

1992 “Helping Your Patients Become Smoke Free in the 90s”

National Habitrol Speakers Training, Short Hills, NJ (Invited)

1992 “Nicotine Substitutes: Short Term Solution or Long Term Cure?”

1992 Cardiovascular Symposium, The Ohio Heart & Vascular Institute at Mount Carmel, Columbus, OH (Invited)

1993 “Use of Transdermal Nicotine Systems with Special Populations: Pregnancy Smokeless Tobacco Use, Cardiovascular Disorders & Psychiatric/Alcoholic Disorders”

14th Annual Meeting Society of Behavioral Medicine, San Francisco, CA (2-hour symposium ED Glover, NL Benowitz, D Hatsukami, JR Hughes, M Stitzer)

1993 “Motivating & Educating Physicians”

Nicotine Replacement & Smoking Cessation: Strategies for Success Speakers Orientation Meeting, Marina Del Rey, CA (Invited)

1994 “Helping Smokers Stop Smoking Utilizing New Treatment Strategies”

109th Meeting of the AAHPERD, Denver, CO (ED Glover, PN Glover) 4-hour symposium.

1994 “How to Publish in Health Education Journals”

109th Meeting of the AAHPERD, Denver, CO (Invited Panel Discussion)

1994 “Evaluating the Newest Approaches to Nicotine Replacement Therapy (Nicotine Oral Inhaler, Nicotine Nasal Spray, Combination Therapy, & the Future”

15th Scientific Meeting of the Society of Behavioral Medicine, Boston, MA (3 1/2 hour symposium ED Glover, MAH Russell, KO Fagerstrom, NG Schneider, SJ Leischow)

1994 “Treating the Nicotine Dependent Person”

18th Society of Otorhinolaryngology & Head-Neck Nurses, San Diego, CA (Invited)

1994 “Treating Smokers in a Wellness Setting: Understanding Nicotine Replacement Therapy”

4th Annual National Symposium on Wellness Facilities & Program Development in Higher Education, Stillwater, OK (Invited)

1994 “Current Smoking Cessation Management Options”

Smoking Cessation Update ‘94-Nurse Practitioner Conference, Baltimore, MD (Invited)

1994 “An Exploratory Pilot-Study in Smoking Cessation Among Chronic Obstructive Pulmonary Patients Using a Nicotine Nasal Spray”

7th National Conference on Nicotine Dependence, Cambridge, MA (ED Glover, PN Glover, M Franzon, A Westin)

1995 “Understanding the Nicotine Gum”

1995 Annual SmithKline Beecham Sales Meeting, Hilton Head, SC (Invited)

1995 “Review of NRT Therapies”

The Experts’ View: What Works in Smoking Cessation, New York, NY (ED Glover, K Monaco, CE Koop, CG Husten, JR Hughes, MC Fiore, VJ Strecher) (Invited)

1995 “Smoking Cessation”

24th Annual Meeting of the Association of Philippine Physicians in America, Cleveland, OH (Invited)

1996 “Effective Smoking Cessation”

111th Meeting of the AAHPERD, Atlanta, GA (ED Glover, PN Glover, C Cerullo, A Greco)

1996 “Bupropion as An Adjunct to Smoking Cessation: A Double-Blind, Placebo-Controlled Dose Response Trial”

9th Meeting of the American Society of Addiction Medicine, Washington DC (RD Hurt, ED Glover, DPL Sachs, LC Dale, DR Schroeder, PN Glover, CR Sullivan, KP Offord, IT Croghan, JA Johnston)

1997 “The Smoking Cessation Efficacy of Varying Doses of Nicotine Delivery Four Years Post Quit Day”

American Lung Thoracic Society, San Francisco, CA (DM Daughton, D. Hatsukami, L Repsher, S Fortmann, ED Glover, E Lichtenstein, S Heatley, T Millatmal, K Lassi, F Ullrich, R Nowak, SI Rennard)

1997 “A Nicotine Sublingual Tablet for Smoking Cessation: Preliminary Data”

Society for Research on Nicotine & Tobacco, Third Scientific Meeting, Nashville, TN (ED Glover, PN Glover, M Franzon, CR Sullivan, PM Sullivan, RM Howell, GG Keyes)

Panel Participant Invited

1997 “A Double-Blind, Placebo-Controlled Dose Response Trial for Smoking Cessation with Bupropion”

Society for Research on Nicotine & Tobacco, Third Scientific Meeting, Nashville, TN

(RD Hurt, DPL Sachs, ED Glover, KP Offord, JA Johnston, LC Dale, MA Krhayrallah, DR Schroeder, PN Glover, CR Sullivan, IT Croghan, PM Sullivan)

1997 “Effectiveness of Bupropion for Smoking Cessation in Subjects with a History of Major Depression or Alcoholism”

American Psychiatric Association Annual Meeting, San Diego, CA. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, Sachs DP, Hurt RD.

1997 “Effective Counseling & Smoking Cessation”

A 90-minute educational satellite broadcast, broadcast to 78 U.S. cities sponsored by Thomas R. Beam, Jr. Memorial Institute, SCP Communications, New Approaches in Smoking Cessation, Raleigh-Durham, NC (ED Glover, CF Koop, M Fiore & M Goldstein) (Invited)

1997 “Bupropion for Smoking Cessation: A Double-Blind Placebo-Controlled Trial”

American College of Chest Physicians (R Hurt, DPL Sachs, ED Glover, KP Offord, JA Johnston, DR Schroeder)

1997 “Habits & Incidence of Smoking Associated Oral Lesions in Recalcitrant Smokers”

75th Annual Dental Hygienist Association Meeting, Atlanta (JC Gibson-Howell, ED Glover, PN Glover, RM Howell, GG Keyes, CR Sullivan, PM Sullivan, M Franzon, B Komives-Norris)

1997 “Smoking Cessation Counseling”

Symposium: Non-Nicotine Management of Smoking Cessation—What Works & Why. National Conference of the American Academy of Nurse Practitioners, New Orleans, (Invited)

1997 “Effectiveness of Bupropion for Smoking Cessation in Subjects with a History of Major Depression or Alcoholism”

American Society of Addiction Medicine National Conference on Nicotine Dependence, Minneapolis, MN. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, Sachs DPL, Hurt RD

1997 “Advertising, Marketing & Health Consequences of Smokeless Tobacco”

Tobacco Use Prevention Summer Seminar Sponsored by Center for Health Promotion & Disease Prevention University of North Carolina, Center for Health Promotion & Disease Prevention University of New Mexico, & Centers for Disease Control & Prevention’s Office on Smoking & Health, Albuquerque, NM (Invited)

1997 “Smoking Cessation: Does Stopping Smoking Reduce the Incidence of MI, &, If So, Which Are the Best Techniques for Reaching That Goal?”

Mount Carmel Health System, Orlando, FL (Invited)

1997 “Efficacy of Bupropion SR on Reducing Craving on Smoking Cessation”

Annual Meeting of the American College of Neuropharmacology, Kamuel, HI (TH Grasela, J Fielder-Kelly, ED Glover, DPL Sachs, JA Johnston)

1998 “A Multi-Center Phase 3 Trial of Lobeline Sulfate for Smoking Cessation”

4th Annual Meeting of the Society for Research on Nicotine & Tobacco , New Orleans, LA (ED Glover, PN Glover, P Tonnesen, L Repsher, J Quiring, FH Schneider, PJ Mione)

1998 “A Comparison of Youth Users & Non-Users of Smokeless Tobacco”

4th Annual Meeting of the Society for Research on Nicotine & Tobacco , New Orleans, LA (LJ Goebel, RD Crespo, RT Abraham, ED Glover)

1998 “Pharmacokinetic & Pharmacodynamic Analysis of the Efficacy & Safety of Bupropion Sustained Release”

American Heart Association Annual Meeting, Dallas, TX (TH Grasela, JA Johnston, ED Glover, DPL Sachs)

1998 “Treating the Nicotine Dependent Patient”

6th National Bolivian American Medical Association Encounter, Charlotte, NC, Invited

1998 “Spit Tobacco: The Ugly Alternative”

Fourth Annual National Conference on Tobacco or Health, St. Paul, MN, Invited

1999 “A Nicotine Sublingual Tablet for Smoking Cessation: 12-Month Data“

5th Annual Meeting of the Society for Research on Nicotine & Tobacco, San Diego,

(ED Glover, PN Glover, M Franzon, CR Sullivan, CL Cerullo, RM Howell)

1999 “Pharmacokinetic & Pharmacodynamic Analysis of the Efficacy & Safety of Bupropion SR”

5th Annual Meeting of the Society for Research on Nicotine & Tobacco, San Diego

(J Fiedler-Kelley, T Grasela, JA Johnston, ED Glover, DPL Sachs)

1999 “The Use of Neural Networks for Data Mining to Identify Predictors of Outcomes in a Double Blind Study”

76th Annual Session & Exposition of the American Association of Dental Schools, Vancouver, British Columbia, Canada (RM Howell, JC Gibson-Howell, ED Glover, GG Keyes, M Franzon, PN Glover)

1999 “How to Intervene: Ask, Advise, Identify, Assist, Arrange”

The ABCs of Smoking Cessation Conference, California Academy of Family Physicians, Long Beach CA (Invited)

1999 “The Practice of Non-Urban Addiction Psychiatry - Treating the Nicotine Dependent Patient”

51st Institute on Psychiatric Services, American Psychiatric Association, New Orleans, LA (CR Sullivan, ED Glover, R Edmundson, M Byre)

1999 “How to Help Your Patients Stop Smoking”

14th Annual Conference of the American Academy of Nurse Practitioners, Atlanta, GA (Invited)

2000 “Efficacy of Bupropion SR for Smokeless Tobacco Cessation”

Inaugural Scientific Meeting of the American Academy of Health Behavior, Santa Fe, NM (ED Glover, J Whoolery, G Hobbs, CL Cerullo, PN Glover)

2001 “Using Bupropion SR for Treating Smokeless Tobacco Dependence”

7th Annual Meeting of the Society for Research on Nicotine & Tobacco, Seattle,

(ED Glover, G Hobbs, CL Cerullo, CR Sullivan, PN Glover)

2001 “Pharmacological Approaches to Treating Nicotine Dependence”

37th Annual Meeting of the American Society of Clinical Oncology, San Francisco,

(Invited)

2002 “Understanding Addiction”

II Annual Scientific Meeting of the American Academy of Health Behavior, Napa Valley CA (R Niaura, ED Glover) (Invited Roundtable)

2002 “Publishing In Health Journals”

II Annual Scientific Meeting of the American Academy of Health Behavior, Napa Valley, CA (ED Glover, J Eddy, M Kittleson, J Price, M Torabi, J Robinson) (Invited Roundtable)

2002 “The Glover-Nilsson Smoking Behavioral Questionnaire”

II Annual Scientific Meeting of the American Academy of Health Behavior, Napa Valley, CA (ED Glover, F Nilsson, A Westin, PN Glover)

2002 “A Nicotine Sublingual Tablet for Smoking Cessation”

II Annual Scientific Meeting of the American Academy of Health Behavior, Napa Valley, CA (ED Glover, PN Glover, M Franzon, R Sullivan, C Cerullo)

2002 “A Double-Blind, Randomized, Placebo-controlled, Multicenter Trial of a Nicotine Inhaler in Smoking Reduction”

8th Annual Meeting of the Society for Research on Nicotine & Tobacco, Savannah, GA (SI Rennard, ED Glover, S Leischow, D Daughton, PN Glover, M Muramoto, T Danielsson, B Landfeldt, A Westin, M Franzon, U Sawe)

2002 “The GN-SBQ”

8th Annual Meeting of the Society for Research on Nicotine & Tobacco, Savannah, GA (ED Glover, F Nilsson, A Westin, PN Glover)

2002 “Addictive Behaviors: Impacting our Professional & Personal Lives”

Keynote for 14th Kentucky Coalition of Nurse Practitioners/Nurse Midwives Conference, Lexington, KY (Keynote, Invited)

2002 “Personal Tobacco Use Behaviors & Tobacco Cessation Activities of Dental & Dental Hygiene Students in US Dental Schools”

Annual American Dental Hygienists’ Association Meeting, Beverly Hills, CA (AS Hatfield, CB DeBiase, CA Spear, ED Glover)

2002. “Comparative Efficacy of Rapid-Release Nicotine Gum Vs. Nicorette in Relieving Smoking Cue-Provoked Craving”

9th Annual Meeting of the Society for Research on Nicotine & Tobacco, New Orleans, LA (R Niaura, M Sayette, S Shiffman, ED Glover, M Nides, M Shelansk, W Shadel)

2003 “Efficacy of the Nicotine Inhaler in Smoking Reduction”

III Annual Scientific Meeting of the American Academy of Health Behavior, St Augustine, FL (SI Rennard, ED Glover, S Leischow, D Daughton, PN Glover, M Muramoto, T Danielsson, B Landfeldt, A Westin, M Franzon, U Sawe)

2003 “Insights into Working with Smokeless Tobacco Users’

Annual Mayo Clinic Nicotine Dependence Conference, Rochester, MN (Invited)

2003 “Methohexital or Thiopental Vs. Remifentanil Alone or in Combination with Thiopental for Electroconvulsive Therapy (ECT)”

13th Annual Meeting of the Association for Convulsive Therapy, San Francisco, CA

2004 “Perspectives on the Role of Low-Nitrosamine Smokeless Tobacco in Reducing Tobacco-Caused Disease” 10th Annual Meeting of the Society for Research on Nicotine & Tobacco, Scottsdale, AZ (J Foulds, ED Glover, KO Fagerstrom, D Hatsukami, K Warner) (Invited)

2004 “Working with Nicotine Dependent Patients’

2nd Annual National Web Conference for AAHPERD Scholar (Invited)

2005 “Efficacy & Safety of the Novel Selective Nicotinic Receptor Partial Agonist Varenicline for Smoking Cessation”

American College of Cardiology Annual Meeting, Orlando FL (C Oncken, E Watsky, K Reeves, R Anziano, the Varenicline Study Group)

2005 “Varenicline is Efficacious & Well Tolerated in Promoting Smoking Cessation: Results from a 7-week, Randomized, Placebo- & Bupropion-Controlled Trial”

Society for Research on Nicotine & Tobacco Annual Meeting, Prague, CR (C Oncken, E Watsky, K Reeves, R Anziano, the Varenicline Study Group)

2005 “Smoking Cessation with Varenicline, a Selective Nicotinic Receptor Partial Agonist: Results of a Phase 2 Study”

Society for Research on Nicotine & Tobacco Annual Meeting, Prague, CR (C Oncken, E Watsky, K Reeves, R Anziano, the Varenicline Study Group)

2005 “Successfully Treating Nicotine Dependence”

Annual AAHPERD National Convention, Chicago, IL (Invited Distinguished Scholar Lecture)

2005 “Evaluation of Actigraphy as a Tool to Characterize Depressive Symptoms: Comparison with the 24-Item Hamilton Depression Inventory”

Annual Drug Information Association Meeting, Washington DC (B Jamerson, M Laflin, A Safavi, ED Glover)

2005 “Sensitivity & Specificity of a Reagent Impregnated Test Strip in Identifying Smokeless Tobacco Users”

Annual IBC Life Sciences Medical Devices Conference, Minneapolis/St. Paul, MN (Glover ED, Glover PN, Laflin MT, Nochur SV)

2005 “New Approaches to Cardiovascular Risk Management: Obesity and Smoking”

79th Annual School Health Conference, Burbank, CA (Invited Independent Session)

2006 “Sensitivity & Specificity of a Reagent Impregnated Test Strip in Identifying Smokeless Tobacco Users”

VI Annual Meeting of the American Academy of Health Behavior, Carmel, CA (Glover ED, Glover PN, Laflin MT, Nochur SV)

2006 “A Pooled-Analysis of Varenicline, an Alpha 4 Beta 2 Nicotinic Receptor Partial Agonist vs. Bupropion for Smoking Cessation”

12th Annual Meeting of the Society for Research on Nicotine & Tobacco, Orlando, FL (DH Gonzales, SI Rennard, CB Billing, KR Reeves, E Watsky, J Gong, the Varenicline Study Group)

2006 “State of the Art of Tobacco Research”

VI Annual Meeting of the American Academy of Health Behavior, Carmel, CA (Invited)

2006 “Current Smokeless Tobacco Use in the United States”

3rd Annual United States Spit Tobacco Summit: Advancing Understanding and Building Collaboration, Mayo Clinic College of Medicine, Rochester, MN (Invited)

2007 “A Pooled-Analysis of Varenicline, An α4β2 Nicotinic Receptor Partial Agonist, Vs Bupropion, for Smoking Cessation”

American College of Clinical Pharmacy, Memphis, TN. (ED Glover, M Nides, CB Billing Jr, KR Reeves, K Williams, on behalf of the Varenicline Study Group)

2007 “Are Instructions for Over-the-Counter (OTC) Nicotine Replacement Therapy (NRT) Products Readable?”

81st Annual American School Health Association Conference, Honolulu, HI. (L Wallace, ED Glover)

2007 “A Multi-Center Phase 3 Trial of Lobeline Sulfate for Smoking Cessation”

Symposium on Addicted & Health Behaviors Research, Amelia Island, FL (ED Glover, PN Glover, P Tonnesen, L Repsher, MT Laflin, J Quiring, JM Rath, E Sharma)

2007 “Cigarette Smoking: A Major Public Health Concern”

Congressional Black Caucus Foundation Annual Legislative Conference, Washington DC (Invited)

2007 “Effect of Nicotine Dependence Level on Quit Outcomes with Varenicline”

National Conference on Tobacco or Health (NCTOH), Minneapolis, MN (ED Glover, S Swartz, D Gonzales, CB Billing Jr, K Williams)

2008 “Nicotine Vaccine Vs Placebo for Smoking Cessation: Long-Term Abstinence & Quitting”

14th Annual Meeting of the Society for Research on Nicotine & Tobacco, Portland, OR (N Rigotti, V Reus, ED Glover, D Tashkin, C Oncken, S Rennard, D Gonzales, D Jorenby, R Akhavain, M Kalnik, M Hohenboken, D Hatsukami)

2008 “Treating Nicotine Dependence with Pharmacological Adjuncts: A Narration”

VIII Annual Meeting of the American Academy of Health Behavior, Oxnard, CA (Presentation for the Research Laureate Medallion)

2008 “Great Manuscript Free to Good Home: Publishing for the Behavioral Science Scholar and Researcher”

VIII Annual Meeting of the American Academy of Health Behavior, Oxnard, CA (Panel Participants: ED Glover, RJ McDermott, R Niaura, B Simons-Morton)

2008 “Gender Differences in a Smoking Cue-provoked Craving Assessment among African Americans Smokers in the DC Metropolitan Area”

Annual American Public Health Association Meeting, San Diego, CA (JK Lok, E Sharma, JM Rath, ED Glover)

2009 “A Qualitative Study to Initiate Future Smokeless Tobacco Dependence Instrument Development”

IX Annual Meeting of the American Academy of Health Behavior, Hilton Head, SC (Lok JK, Rath JM, Clark RI, Glover ED)

2009 “Helping Smokers Quit with Varenicline: Is It Safe?”

19th Annual Art and Science of Health Promotion Conference, San Francisco, CA

2009 “Placing Nicotine Addiction Into Context: An Interdisciplinary Approach to Addressing Smoking Cessation”

Combined Annual American Heart Association and Annual Cardiology Scientific Meeting, Orlando, FL. (Invited)

2010 “Understanding and Treating Nicotine Dependence”

Annual PrimCare Congress, Ft Lauderdale, FL (Invited)

2012 “Biomarkers of Cigarette Smoking & Association with Vaginal Microbiota”

National STD Prevention Conference, Minneapolis, MN (Brotman RM, Glover ED, Banchero B, Nandy M, Sawyer M, Rath J)

2013 “Publishing in Academic Journal”

Hispanic-Serving Health Professions Schools, Bethesda, MD (Invited)

(Regional)

1973 “Motivations of the Indigent Child”

Southern District AAHPERD Convention, Jackson, MS

1986 “Prevalence, Intentionality & Age of Initiation of Smokeless Tobacco in Male Public School Children in Oklahoma”

Southern District AAHPERD Convention, Winston-Salem, NC (ED Glover, SW Edwards, M Laflin)

1987 “Health Consequences of Smokeless Tobacco & Implications for Health & Physical Educators”

Southern District AAHPERD, Birmingham, AL (ED Glover, SM Hunter)

1987 “Comparing the Personality of the Cigarette Smoker & Smokeless Tobacco User”

Southern District AAHPERD, Birmingham, AL (ED Glover, EW Edmundson, D Holbert, PP Alston)

1987 “Tobacco: The Whole Picture”

Tri-State American Lung Association Meeting, Atlanta, GA

1988 “Identifying Patterns of Moist Snuff Use Among College Males”

Southern District AAHPERD, Little Rock, AR (ED Glover, D Flannery)

1989 “Acute Effects of Snuff on Cardiovascular Responses During Exercise”

Southern District AAHPERD, Chattanooga, TN (ED Glover, D Flannery, D Holbert, L Smith)

1990 “Prevalence & Patterns of Smokeless Tobacco Use Among Athletes & Nonathletes”

Regional ASHA/PSHA, Philadelphia, PA (ED Glover, AC Donohoe)

1993 “Cardiac Risk Factor Modification: Contemporary Management of Nicotine Dependence”

2nd Annual Tri-State Cardiology Update, Sponsored by the West Penn Cardiovascular Institute, Stubenville, OH (Invited)

1993 “Treating the Nicotine Addicted Patient”

Teleconference at 14 sites in Missouri & Illinois (Invited)

1995 “Treating the Nicotine Addicted Patient”

Rural Alcohol & Other Drug Abuse Prevention Conference, Athens, OH (Invited)

2000 “Update on Smokeless Tobacco”

American Cancer Society Summit 2000, Baltimore, MD (Invited)

2000 “The Implementation of AHCPR Guidelines for Smoking Cessation”

The Health Plan, Wheeling, WV (Invited) (Glover ED, Glover PN)

2000 “Pharmacists & Smoking Cessation”

Regional Meeting of the Maryland Pharmacists Association, Virginia Pharmacists Association & the Washington DC, Pharmacists Association, Tysons Corner, MD (Invited)

2007 “Prevalence, Trends and the Future of Smokeless Tobacco Products”

Spit Tobacco: You’re Out! A Grassroots Approach to Knock Spit Tobacco Out of Your Community, Charlotte, NC (Invited)

(State)

1977 “Creative Strategies for Prevention of Abusive Behavior”

Kansas AHPERD, Wichita, KS

1977 “Testimony in Defense of Senate Bill 146”

State Legislature, Non-smokers’ Rights, Topeka, KS

1977 “Instructional Methods & Materials for Middle School & High School Health Programs”

Kansas AHPERD, Topeka, KS

1977 “The Physical Side of Aging: An Experiential View of the Aging Process”

1st Gerontological Institute, Lawrence, KS

1978 “Confronting Aging”

Kansas Public Health Association Meeting, Topeka, KS

1978 “Learning to Live a Lifetime”

32nd Health Education Workshop, Kansas Depart of Health & Environment, Hays, KS

1978 “Death Education in the Schools”

Kansas AHPERD, Lawrence, KS

1979 “Improving the Quality of Life for the Aged”

Veterans Administration Medical Center, Topeka, KS

1979 “Aging: A Losing Proposition”

Texas School Health Association, Dallas, TX

1979 “Update - The Texas School Health Education Study”

56th Meeting, Texas AHPERD, Fort Worth, TX

1980 “Sports Science in the 80’s”

83rd Texas Academy of Science, Corpus Christi, TX

1980 “The Texas School Health Education Study”

Texas School Health Association, Houston, TX

1980 “Teaching & Learning About Aging in the Classroom”

28th Conference, Texas Council for the Social Studies, Dallas, TX

1980 “Health Knowledge of Black Freshman in Predominantly Black Colleges & Universities in Texas”

57th Convention, Texas AHPERD, San Antonio, TX

1982 “Can You Cope with Death?”

Texas School Health Association, San Antonio, TX

1982 “Sex Differences in Health Knowledge Among College Freshman”

Texas School Health Association, San Antonio, TX

1982 “Session for Smoking Cessation Facilitators”

Texas Public Health Association & Texas SOPHE, Austin, TX

1982 “Use of Smokeless Tobacco Among Young People in the American Southwest”

2nd Southwest Cultural Festival, Stillwater, OK

1982 “Youth Smoking Cessation Clinics”

Oklahoma AHPERD, Wagoner, OK

1984 “Use & Knowledge of Smokeless Tobacco: A Survey of Students in Texas Schools”

Texas School Health Association, Corpus Christi, TX (ED Glover, A Henderson, M Dees)

1984 “Smokeless Tobacco & Cancer”

Oklahoma Health Education Council, Oklahoma City, OK

1984 “Leukoedema, Leukoplakia, Oral Carcinoma & Smokeless Tobacco”

Oklahoma AHPERD, Shangri-la, OK (ED Glover, V Cleaver)

1984 “Current Research in Smokeless Tobacco”

Oklahoma AHPERD, Shangri-la, OK (ED Glover, SW Edwards)

1985 “Smokeless Tobacco”

Annual, American Cancer Society Convention, Raleigh, NC

1985 “A Comparison Among High School Seniors in Health Knowledge”

Oklahoma AHPERD, Edmond, OK (ED Glover, SW Edwards)

1985 “Prevalence of Smokeless Tobacco Use in a North Carolina University”

North Carolina AHPERD, Greensboro, NC (ED Glover, PP Alston, EW Edmundson)

1986 “Ethical Dilemma: Tobacco or Health?”

North Carolina SOPHE, Charlotte, NC

1986 “Health Consequences of Smokeless Tobacco”

4th North Carolina Leadership Conference, Reidsville, NC (Invited)

1986 “University Students Intentions Regarding the North Carolina 21-Year Drinking Age Law”

North Carolina AHPERD, Greensboro, NC (JF Lotterhos, ED Glover, D Holbert)

1986 “Personality Profiles Associated with Dippers, Chewers & Nonusers of Smokeless Tobacco”

North Carolina AHPERD, Greensboro, NC (ED Glover, EW Edmundson, PP Alston, D Holbert, DH Chenoweth, DM White)

1986 “Tobacco: Its Implications for Public Education”

Annual, Synergy Conference, Camp Caraway, NC (Invited)

1987 “Smokeless Tobacco: Have We Bitten Off More Than We Can Chew?”

64th South Carolina Public Health Association, Myrtle Beach, SC

1987 “Cigarette Smoking: Cardiovascular, Respiratory Problems & Cancer”

64th South Carolina Public Health Association, Myrtle Beach, SC

1987 “Anatomy of Smokeless Tobacco”

Annual North Carolina Medical Auxiliary, Pinehurst, NC (Invited)

1987 “Smokeless Tobacco & Cancer”

4th North Carolina Health & Promotion Institute, Raleigh, NC (Invited)

1987 “Overview of Research Related to Smokeless Tobacco Use: Implications for Community Health Practice”

Annual Pennsylvania Public Health Association, Tamiment, PA (ED Glover, RW St. Pierre, LK Olsen)

1987 “Highlighting the Antismoking Issues”

Annual Florida American Cancer Society Meeting, Miami, FL (Invited)

1987 “How To Live To Be A 100 (And Live Better!)”

5th North Carolina Leadership Conference, Reidsville, NC (Invited)

1987 “The Impact of the North Carolina 21-Year Age Drinking Law”

North Carolina AHPERD Meeting, Greensboro, NC (JF Lotterhos, ED Glover, D Holbert)

1988 “Smokeless Tobacco: Are Our Youth Feeling the Pinch?”

Pennsylvania School Health Association, Philadelphia, PA

1988 “Smokeless Tobacco & Oral Cancer”

Annual Pennsylvania School Dental Hygienists Meeting, Shamokin Dam, PA (Invited)

1988 “Implications of Smokeless Tobacco for the Health Professional”

28th North Carolina Public Health Association, Kill Devil Hills, NC (Invited)

1988 “The Effects of Smokin’, Dipping, & Chewing“

North Carolina Governor’s Health Conference, Raleigh, NC (Invited)

1988 “How to Get Published”

NCAHPERD, Greensboro, NC (ED Glover, L Berne, R Frye, A Daniels) (Invited)

1988 “Prevalence of Smokeless Tobacco in the United States”

2nd State Conference on Smokeless Tobacco, Indianapolis, IN (Invited)

1988 “Cessation & Smokeless Tobacco”

2nd State Conference on Smokeless Tobacco, Indianapolis, IN (Invited)

1989 “Snuffing Out Tobacco”

Annual Pennsylvania School Dental Hygienists Meeting, State College, PA (Invited)

1989 “Oral Cancer & the Dental Hygienist”

Annual Pennsylvania Dental Hygienists Association, Williamsport, PA (Invited)

1989 “Prevalence & Patterns of Smokeless Tobacco Use in Pennsylvania Colleges & Universities”

Annual Pennsylvania Public Health Association, Pittsburgh, PA (B Cinelli, M Rose-Colley, ED Glover)

1989 “Your Mouth, Your Lungs, Your Life: Your Choice”

27th Annual Workshop, State Medical Society of Wisconsin, Oshkosh, WI (Invited)

1990 “An Overview of Smokeless Tobacco Use”

West Virginia State Health Education Council Meeting, Davis, WV (Invited)

1990 “Smokeless Tobacco Cessation”

West Virginia State Health Education Council Meeting, Davis, WV (Invited)

1990 “Smokeless Tobacco Issues in Schools”

West Virginia Leaders of Learning Conference, Charleston, WV (Invited)

1990 “Adolescent Use of Tobacco”

3rd Annual High Risk Conference, Bristol, VA (Invited)

1990 “Parameters of Tobacco Control: Policy, Services & Media”

West Virginia Tobacco Control Coalition, Charleston, WV (Invited)

1991 “Tobacco Cessation”

West Virginia Association of Alcoholism & Drug Abuse Counselors, Canaan, WV (Invited)

1991 “Smokeless Tobacco Update”

American Cancer Society Annual Meeting, West Virginia Division, Charleston, WV (Invited)

1991 “Volunteerism”

American Cancer Society Annual Meeting, West Virginia Division, Charleston, WV (Invited)

1991 “Pharmacological Nicotine Adjuncts for Smoking Cessation”

West Virginia Psychological Association, Pipestem, WV (Invited)

1992 “Smoking Cessation: New Therapy Options for Smoking Dependence”

32nd WVU Alumni Seminar & 7th Annual Pharmacy Law Lecture, Morgantown, WV (Invited)

1992 “How to Help Your Patients Stop Smoking”

93rd Annual Convention of the Texas Osteopathic Medical Association, Corpus Christi, TX (Invited)

1992 “Tobacco: The Whole Picture”

Virginia Governor’s Conference on Alcohol & Substance Abuse, Norton, VA (Invited)

1992 “Nicotine Reduction Therapy in Smoking Cessation/Questions About “The Patch”

Ohio American Cancer Society & Ohio State University, Columbus, OH (Invited)

1992 “Nicotine Addiction & Smokeless Tobacco”

West Virginia Addiction Training Institute, Morgantown, WV (Invited)

1992 “Smoking Cessation Therapy Update”

Annual Conference of the West Virginia College of Osteopathic Medicine, Kiawah Island, SC (Invited)

1992 “New Options for Smoking Dependence”

Florida Osteopathic Medical Association, West Palm Beach, FL (Invited)

1992 “Tobacco Use Today”

Treatment Strategies for Nicotine Addiction Conference, Morgantown, WV (Invited)

1992 “Nicotine as an Addiction”

Treatment Strategies for Nicotine Addiction Conference, Morgantown, WV (Invited)

1992 “New Therapy Options for Smoking Dependence”

Jefferson County Medical Society, Steubenville, OH (Invited)

1992 “Treatment of Nicotine Dependence”

The Southwestern Virginia Medical Society Fall Conference, Radford, VA (Invited)

1992 “New Therapy Options for Smoking Cessation”

Cardiovascular Update: A Symposium for Physicians & Nurses, Warren, OH (Invited)

1992 “Update on Nicotine Addiction & Treatment”

Conference on Office Based Treatment of Addictions, Pittsburgh, PA (Invited)

1992 “How to Help Your Patients Stop Smoking”

Alderson-Broaddus College, Philippi, WV (Invited)

1992 “Complexity of Nicotine Addiction”

How to Help Your Patients Stop Smoking, Temple University, Philadelphia, PA (Invited)

1992 “New Therapy Options for Smoking Cessation”

2nd Annual Cancer Conference, Huntington, WV (Invited)

1992 “Smoking Cessation Update”

44th Scientific Assembly, South Carolina Academy of Family Physicians, Hilton Head, SC (Invited)

1992 “How to Help Your Patient Stop Smoking--New Treatment Strategies”

Annual Family Practice Review, Central Ohio Academy of Family Physicians, Columbus, OH (Invited)

1992 “Tobacco Addiction & Its Treatment”

Virginia Philippine Medical Association, Alexandria, VA (Invited)

1993 “Treating Your Patients for Nicotine Addiction”

Indiana County Medical Society, Indiana, PA (Invited)

1993 “Current Treatments for Nicotine Addiction”

28th Annual Postgraduate Seminar, Cleveland Academy of Osteopathic Medicine, Cleveland, OH (Invited)

1993 “The Effects of Smokeless Tobacco & Cigarettes on Athletic Participation”

Annual Virginia Academy of Family Physicians Meeting, Hot Springs, VA (Invited)

1993 “Don’t Chew on This”

Toward a Tobacco-Free West Virginia: Healthy Communities Working for Change, Barboursville, WV (Invited)

1993 “Smoking Cessation”

45th Annual Scientific Assembly, North Carolina Academy of Family Physicians, Charlotte, NC (Invited)

1993 “New Treatment Options for Smoking Cessation”

41st Annual Scientific Assembly, West Virginia Academy of Family Physicians, Morgantown, WV (Invited)

1993 “Smoking Cessation Update: 1993”

Pennsylvania Society of Hospital Pharmacists, Mt. Washington, PA (Invited)

1993 Medical Therapy Options for Smoking Dependence”

Southwest Virginia Hospital Pharmacists, Abington, VA (Invited)

1993 “Youth & Tobacco”

14th Annual Meeting of the State Health Education Council of West Virginia, Canaan Valley, WV (Invited)

1993 “How to Help Patients Stop Smoking: New Treatment Strategies”

4th Annual Meeting of the Delaware Academy of Medicine, Wilmington, DE (Invited)

1993 “New Nicotine Pharmacological Adjuncts for Helping People Quit Smoking”

Conference on Nursing Care of the Head & Neck Cancer Patient, Department of Otolaryngology & Human Communication & the Society of Otorhinolaryngology & Head-Neck Nurses, Inc. Milwaukee, WI (Invited)

1993 “An Overview of Smoking Cessation Methods: Past & Present”

27th Annual Ohio Health Care Forum, Pittsburgh, PA (Invited)

1993 “Smoking Cessation”

19th Annual Montana Society for Respiratory Care, Helena, MT (Invited)

1993 “Eliminating Second-Hand Smoke Through Smoking Cessation”

Cardiovascular Conference for Nurses, Mobile, AL (Invited)

1993 “Practical Solutions to Implementing & Evaluating a Smoke-Free Environment”

Solutions for Workplace Smoking: Corporate Issues, Evansville, IN (Invited)

1993 “Smokeless Tobacco”

West Virginia Addiction Training Institute, Morgantown, WV (Invited)

1993 “The Quitting Factor: Assisting Women in Smoking Cessation”

Women’s Health Initiative: Addressing the Management of Major Health Issues in the 90’s, Milwaukee, WI (Invited)

1993 “Nicotine Addiction”

32nd Annual Medical Seminar, AIDS & Addictions, Halifax Regional Hospital, South Boston, VA (Invited)

1993 “Cigarette Smoking Cessation”

10th Annual Philippine Medical Association, WV Chapter, Charleston, WV (Invited)

1993 “The Power of Nicotine Transdermal Patches”

Kentucky American Cancer Society, 6-hr Seminar, Louisville, KY (Invited)

1993 “Cigarettes & Psychiatric Illness -- Practical Approaches to Cessation”

The Interface of Medicine & Psychiatry, Towson, MD (Invited)

1994 “Epidemiology of Tobacco”

Conference on Treatment of the Nicotine Dependent Patient, Cleveland, OH (Invited)

1994 “Nicotine as an Addictive Drug”

Conference on Treatment of the Nicotine Dependent Patient, Cleveland, OH (Invited)

1994 “Criteria for Selecting a Nicotine Transdermal System”

Conference on Treatment of the Nicotine Dependent Patient, Cleveland, OH (Invited)

1994 “Smoking Cessation”

14th Annual South Central Respiratory Care Symposium & the Pennsylvania Society of Critical Care Medicine, Seven Springs Mountain Resort, Champion, PA (Invited)

1994 “Smoking Cessation”

16th Annual Spring Symposium, West Virginia Academy of Physician Assistants, Oglebay, Wheeling, WV (Invited)

1994 “Nicotine & Its Role in Tobacco Addiction, Cessation, & Treatment”

Wellness ‘94, Morgantown, (ED Glover, PN Glover) (Invited)

1994 “Smokeless Tobacco: This is What We Know”

Tobacco Reduction in Rural Communities: A California Conference for Rural Tobacco Educators, Yosemite, CA (Keynote, Invited)

1994 “Smokeless Tobacco Behavior Techniques - 1 (Prevention)”

Tobacco Reduction in Rural Communities: A California Conference for Rural Tobacco Educators, Yosemite, CA (Invited)

1994 “Smokeless Tobacco Behavior Techniques - 2 (Cessation)”

Tobacco Reduction in Rural Communities: A California Conference for Rural Tobacco Educators, Yosemite, CA (Invited)

1994 “Preventing Tobacco Use Among Young People: A Report of the Surgeon General”

West Virginia Tobacco Control Coalition Annual Meeting, The Building Blocks to a Tobacco-Free State, Parkersburg, WV (Invited)

1994 “The Surgeon General’s Report on Youth & Tobacco”

Annual D.A.R.E. Officer’s Association Conference, Huntington, WV (Invited)

1994 “Tobacco Prevention”

Maryland Department of Education, Summer Health Education Training Institute, St. Mary’s College, MD (Keynote, Invited)

1994 “Building Resistance Skills”

Maryland Department of Education, Summer Health Education Training Institute, St. Mary’s College, MD (Invited)

1994 “Spit Tobacco: It’s BA-ACK! Who Uses? Why? Cessation Strategies”

Ohio Tobacco Control Resource Group & the Ohio Department of Health, Mohican State Park, OH (Invited)

1994 “Tobacco Use”

Healthy People 2000: Delivering the Promise Symposium, Denton, TX (Invited)

1994 “Tobacco Cessation”

46th Annual Scientific Assembly of the Tennessee Academy of Family Practice, Gatlinburg, TN (Invited)

1995 “Implications of the Nicotine Gum & the Nicotine Patch Going OTC”

California Department of Health Services, Local Lead Agency Project Director’s Conference, San Diego, CA (Invited)

1995 “The Addictive Process”

3rd Statewide Kentucky Chronic Disease Conference, Lexington, KY (Invited)

1995 “Effective Cessation Strategies”

3rd Statewide Kentucky Chronic Disease Conference, Lexington, KY (Invited)

1995 “Tobacco Prevention & Education Strategies: Smoking”

Florida Statewide Prevention Conference, Orlando, FL (Invited)

1995 “Tobacco Prevention & Education Strategies: Smokeless Tobacco”

Florida Statewide Prevention Conference, Orlando, FL (Invited)

1995 “Incorporating NRT into Freshstart”

American Cancer Society, Nevada Division, Las Vegas, NV (Invited)

1995 “State of the Art Methods for Assisting Your Clients to Quit Using Tobacco for Good”

Ventura County Public Health Tobacco Education & Control Coalition Member Organizations, Thousand Oaks, CA (Invited)

1995 “Assisting Tobacco Addicted Persons to Quit the Use of Tobacco”

Indiana Medical Society, Indiana, PA (Invited)

1995 “Tobacco Implications for Cancer”

West Virginia State Cancer Registrars Association, Morgantown, WV (Invited)

1995 “The Use of Nicotine Therapy in Treating Tobacco Addictions”

7th Annual St. Thomas Hospital Multidisciplinary Conference on Addictions, Akron, OH (Invited)

1995 “Tobacco as an Addiction: Strategies for Intervention”

5th Annual Cancer Conference, Huntington, WV (Invited)

1996 “Smokeless Tobacco Use”

4th Annual West Virginia Tobacco Control Conference, Charleston, WV (Invited)

1996 “Understanding Nicotine Addiction & How to Treat It”

Tobacco Use Prevention & Healthcare Meeting, Charleston, WV (Invited)

1996 “Smoking Cessation: NCI Intervention Guidelines”

The Breast & Cervical Cancer Information Program, Clarksburg, WV (Invited)

1996 “Nicotine Replacement Therapy”

Tobacco -- Getting It Out of Our System Conference, Bristol, TN (Keynote, Invited)

1996 “Smoking Cessation During Pregnancy”

Tobacco -- Getting It Out of Our System Conference, Bristol, TN (Invited)

1996 “Smoking & the Workplace”

Wellness Council of West Virginia-Northern Panhandle Chapter, Wheeling, WV (Invited)

1996 “Smokeless Tobacco”

3rd Annual Kentucky Oral Health Consortium (University of Louisville School of Dentistry, University of Kentucky College of Dentistry, Kentucky Dental Association) Lexington, KY (Invited)

1996 “Smokeless Tobacco”

3rd Biennial Alcohol, Tobacco & Other Drug Abuse Prevention Conference, Snowshoe, WV (Invited)

1997 “Epidemiology: Who is Smoking?”

Treating the Nicotine Dependent Patient Conference, Charleston, WV (Invited)

1997 “Treating the Nicotine Dependent Patient”

Treating the Nicotine Dependent Patient Conference, Charleston, WV (Invited)

1997 “Treating the Nicotine Dependent Patient with the Latest Pharmacological Adjuncts”

CME Conference - Current Issues in Psychiatry: Addiction & Schizophrenia, Hot Springs, VA (Invited)

1997 “New Treatment Strategies for Smoking Cessation”

Rutherfordton Medical Society, Rutherfordton, NC (Invited)

1997 “Biology of Addiction”

The Mid-Atlantic “Clearing the Air Program, Bethesda, MD (Invited)

1997 “New Treatment Therapies for Smoking Cessation”

The Mid-Atlantic “Clearing the Air Program, Bethesda, MD (Invited)

1997 “The Biology of Addiction”

Camcare Health Education & Research Institute, Charleston, WV (Invited)

1997 “Smoking Cessation”

11th Annual Family Practice Weekend & Sports Medicine Conference, Huntington, WV (Invited)

1998 “The Addiction of Smoking…How Employers Can Help”

The Wellness Council of the Midlands & the Omaha Community Partnership, Omaha, NE (Invited)

1998 “Update Smokeless Tobacco”

Southeastern Idaho Dental Hygienists, Pocatello, ID (Invited)

1998 “Smoking & Depression’

8th Annual Yon Symposium, Portsmouth, VA (Invited)

1998 “Treating the Nicotine Dependent Patient”

Keynote Address, 9th Annual Addiction Training Institute, Morgantown, WV (Keynote, Invited)

1998 “Pharmacological Approach to Nicotine Dependence”

New Smoking Cessation Strategies: 1998 Conference, Falls Church, VA (Invited)

1999 “Advances in the Management of Smoking Cessation”

Delaware American Cancer Society & the Medical Society of Delaware, Wilmington, DE (Invited)

1999 “Pipes, Cigars, & Smokeless Tobacco”

Virginia American Cancer Society, Norfolk, VA (Invited)

1999 “Treating the Nicotine Dependent Smokeless Tobacco Patient”

New Strategies in Smokeless Tobacco Cessation, Flatwoods, WV (Invited)

1999 “Biology of Addiction”

Primary Care Issues in Women’s Health, Norton HealthCare, Louisville, KY (Invited)

1999 “Smoking Cessation”

Primary Care Issues in Women’s Health, Norton HealthCare, Louisville, KY (Invited)

1999 “Smoking Cessation”

7th Annual, West Virginia Association of Cardiovascular & Pulmonary Rehabilitation, Sutton, WV (Invited)

1999 “Treating the Nicotine Dependent Patient”

7th West Virginia Rural Health Conference, Barboursville, WV (with PN Glover) (Invited)

1999 “Nicotine Dependency”

Appalachian Consortium Conference, The Practice of Health in Tobacco-Growing Communities: New Partners for Today’s Challenges, Abingdon, VA (Invited)

2000 “Advances in the Management of Smoking Cessation”

Nicotine in the Millennium: A Statewide Nicotine Summit, Baltimore, MD (Keynote, Invited)

2000 “Effective Counseling Strategies”

Nicotine in the Millennium: A Statewide Nicotine Summit, Baltimore, MD (Invited)

2000 “Nicotine Addiction During Treatment for Other Substance Abuse Disorders”

Virginia Association of Alcohol & Drug Abuse Counselors, Virginia Beach, VA

(ED Glover, PN Glover) (Invited)

2000 “Implementing the AHCPR Guidelines for Smoking Cessation”

Virginia Association of Alcohol & Drug Abuse Counselors, Virginia Beach, VA

(ED Glover, PN Glover) (Invited)

2000 “Impact of Nicotine Addiction on Substance Abuse Treatment”

Virginia Association of Alcohol & Drug Abuse Counselors, Virginia Beach, VA

(ED Glover, PN Glover) (Invited)

2000 “Smoking Cessation”

Fall Conference: Novel Approaches to Lung Cancer Management, Morgantown, WV (Invited)

2001 “Understanding Nicotine Addiction”

BeCause: Tobacco Cessation: State-of-the Art Interventions, Charleston, WV (Invited)

2001 “Successful Smoking Cessation Strategies”

13th Annual Conference Toward Excellence in Primary Care & Midwifery, Kentucky Coalition of Nurse Practitioners / Nurse Midwives, Louisville, KY (Invited)

2001 “Tobacco Update for Public Health Professionals”

The Risky Business Conference, Western Maryland College, Westminster, MD (Invited)

2003 “Spit Tobacco, Prevention, Addiction, Intervention, & Cessation”

The National Spit Tobacco Education Program & Desoto Family Dental Group, University of Tennessee Health Science Center, Department of Dental Hygiene & College of Dentistry, 7th District Dental Society, & Memphis Dental Hygienists’ Association, Nov 2003

2004 “Treating Nicotine Dependence Today & in the Future”

Keynote session for the 2nd Statewide Tobacco Summit, Baltimore, MD (Keynote, Invited)

2004 “Modifiable Risk Factors: Tobacco Use”

Colorectal Cancer: Current Concepts in Prevention, Diagnosis, & Treatment, Sponsored by the University of Maryland School of Medicine, the University of Maryland Statewide Health Network (UMSHN), the Western Maryland Health System, the Allegany County Health Department, the South Atlantic American Cancer Society, & the Maryland Cooperative Extension Rocky Gap, MD (Invited)

2004 “Reducing Fat & Kicking Butts: A New Approach to Cardiovascular Risk Management”

Cleveland State University Biomedical & Health Institute, Cleveland, OH (Invited)

2007 “Smoking Cessation or Treating Nicotine Dependence?”

Nurse Practitioner Association of the District of Columbia, Washington DC (Invited)

2007 “Trends in Treating Nicotine Dependence”

Maryland Academy of Physician Assistants Annual Meeting, Ocean City, MD (Invited)

2008 “The Latest Treatment Options and Research for Helping Smokers Quit”

Salisbury University, Salisbury, MD (Invited)

2012 “Update on Tobacco Addiction”

University of Hawaii Cancer Center, Honolulu, HI (Invited)

2012 “Understanding and Treating Nicotine Dependence”

University of North Texas Health Science Center, Ft Worth, TX (Invited)

2012 “Tobacco: Addiction and/or Habit”

University of Hawaii School of Public Health Distinguished Lecture Series, Honolulu, HI (Invited)

2013 “Successfully Treating Nicotine Dependent Patients”

Tulane University School of Public Health, New Orleans, LA (Invited)

2014 “It’s Time to Write it Up: Insights into Publishing Your Work”

College of Education 2014 Colloquium, University of Houston, Houston, TX (Invited)

2014 “Anatomy of Addiction”

Anxiety and Health Research Laboratory/Substance Use Treatment Clinic, 2014 Colloquium, University of Houston, Houston, TX (Invited)

2014 “Smoking Cessation”

65th Annual Spring Symposium, Carilion Clinic, Roanoak, Va (Invited)

2014 “Tips on Publishing in Professional Journal”

University of Texas, School of Nursing, Arlington, TX (Invited)

2014 “Understanding and Treating Nicotine Dependency”

West Virginia University Health Sciences Center, School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown WV (Invited)

PUBLICATIONS:

Articles Refereed

‘76 Merki DJ, Glover ED. Health education experiences in Texas senior high schools. Texas Association for Health, Physical Education & Recreation Journal, 44(2):6-7, 44.

‘77 Glover ED. The influence of subliminal perception on smoking behavior. Abstracts Research Papers 1977 AAHPERD, AAHPERD Publications, 97.

‘77 Glover ED. The effects of televised violence on aggressive behavior in children. Kansas Association for Health, Physical Education & Recreation Journal, 45(2):8-10.

‘77 Glover ED. Cigarette smoking among youth - an increasing problem. Kansas Association for Health, Physical Education & Recreation Journal, 45(3):12-13.

‘77 Glover ED, Laflin M. Assertiveness & nonsmokers. Health Education, 8(6):23-25.

‘78 Glover ED. Modeling: A powerful change agent. Journal of School Health, 48(3):175-176.

‘78 Glover ED. Aging awareness. Kansas Association for Health, Physical Education & Recreation Journal, 46(2):12-13.

‘78 Glover ED. Health hazards of pipe & cigar smoking. Kansas Association for Health, Physical Education & Recreation Journal, 46(31):22-23.

‘79 Glover ED, Dunleavy A. The prediction of probable susceptibility to a subliminal stimulation strategy of smoking behavior modification. Research Papers - ASHA, 8.

‘79 Glover ED. Decreasing smoking behavior through subliminal treatments. Journal of Drug Education,9(3):273-283.

‘81 Christen AG, Glover ED. Smokeless tobacco: Seduction of youth. World Smoking & Health, 6(2):20-24.

‘81 Glover ED, Christen AG, Henderson AH. Just a pinch between the cheek & gum. Journal of School Health, 51(6):415-418.

‘81 Glover ED, Baffi CR, Redican KJ. Experiential activities for the early adolescent. Journal of SchoolHealth, 51(8):553-557.

‘81 Glover ED, Henderson AH. The implementation of youth smoking cessation clinics in Texas. TexasAssociation for Health, Physical Education & Recreation Journal, 50(1):8-9,61-62.

‘82 Glover ED, Henderson AH. Report of the Texas school health education study. Texas Association for Health, Physical Education & Recreation Journal, 50(2):6-7,51-55.

‘82 Glover ED. Back to the basics. Journal of Texas School Board, 28(1):14-15.

‘82 Glover ED, Christen AG, Henderson AH, Adams EE. Cigarette smoking: Addiction and/or habit Health Values, 6(2):26-30.

‘82 Glover ED, Christen AG. Smokeless tobacco today. Texas Association for Health, Physical

Education & Recreation Journal, 50(3):10-12, 45-46.

‘82 Glover ED, Christen AG, Henderson AH. Smokeless tobacco & the adolescent male. Journal of Early Adolescence, 2(1):1-13.

‘82 Christen AG, Glover ED, Adams EE. Six persistent “myths” about tobacco use. Health Education, 13(4):35-37.

‘82 Glover ED. A health educator looks at medicine. Health Values, 6(4):33-34.

‘82 Christen AG, Swanson BZ, Glover ED, Henderson AH. Smokeless tobacco: The folklore & social history of snuffing, sneezing, dipping & chewing. Journal of the American Dental Association, 105:821-829.

‘83 Christen AG, Glover ED. Psychological satisfactions from smoking cigarettes in 57 dental patients. Journal of Drug Education, 13(1):95-102.

‘83 Glover ED, Edwards SW, Christen AG. Smokeless tobacco a merging concern. Abstracts 5th World Conference on Smoking & Health, Canadian Council on Smoking & Health, 60-61.

‘83 Hough BJ, Glover ED. The interrelationship of the macrocosm of living & the microcosm of dying. Health Values, 7(5):16-19.

‘83 Glover ED. The use of smokeless tobacco among young people in the American southwest.

Southwest Cultural Heritage Festival 1982, Oklahoma State University Press, 79-92.

‘83 Glover ED, Edwards SW. Smokeless tobacco: Past, present & future perspectives. Oklahoma Association for Health, Physical Education, Recreation & Dance Journal, 16(1):7-10.

‘84 Glover ED. Acquired immune deficiency syndrome (AIDS): Number one priority. Health Values, 8(2):3-12.

‘84 Glover ED, Edwards SW, Christen AG, Finnicum P. Smokeless tobacco research: An

interdisciplinary approach. Health Values, 8(3):21-25.

‘84 Glover ED. Herpes: Removing fact from fiction. Health Education, 15(5):6-10.

‘84 Glover ED. Health education in Texas. Journal of School Health, 54(8):310-311.

‘85 Christen AG, Glover ED. Tobacco education & quit smoking programs in the dental office & community: The why’s & wherefore’s. Oral Health, 75(2):83-88.

‘85 Glover ED, Edwards SW, Finnicum P. The acute effects of smokeless tobacco on heart rate & motor performance. Society of Behavioral Medicine-Addendum, 24.

‘85 Glover ED. Health consequences of smokeless tobacco. Tobacco Issues, U.S. Government Printing Office, Washington DC, Serial No. 99-41, 120-140.

‘85 Glover ED, Edwards SW, Tedford H. The Oklahoma smokeless tobacco survey. Oklahoma Association for Health Education, Recreation & Dance Journal, 17(1):15.

‘85 Glover ED, Cleaver V. Leukoedema, leukoplakia, oral carcinoma & smokeless tobacco. Oklahoma Association for Health, Physical Education, Recreation & Dance Journal, 7(1):15.

‘85 Glover ED, Johnson R, Laflin M. Smokeless tobacco use trends in the United States among college students. 12th World Conference on Health Education - Abstracts, 50.

‘85 Schaefer SD, Henderson AH, Glover ED, Christen AG. Patterns of use & incidence of smokeless tobacco consumption in school-age children. Archives of Otolaryngology, 111(10):639-642.

‘85 Glover ED, Alston PP, Edmundson EW. Prevalence of smokeless tobacco in a North Carolina University. Research Presentations, 1985 NCAHPERD, 8.

‘85 Glover ED. Smokeless tobacco: A future health concern for North Carolina North Carolina Medical Journal, 46(10):549-550.

‘85 Glover ED, Edwards SW. A comparison among high school seniors on health knowledge. Oklahoma Association for Health, Physical Education, Recreation & Dance Journal, 18(2):7.

‘86 Glover ED, Edmundson EW, Alston PP, Holbert D, Chenoweth DH, White DM.

Personality profiles associated with dippers, chewers & nonusers of smokeless tobacco. Research NCAHPERD, 22.

‘86 Lotterhos JF, Glover ED, Holbert D. University intentionality regarding the North Carolina 21-year drinking age law. Research NCAHPERD, 17.

‘86 Glover ED. Regional prevalence & patterns of smokeless tobacco use. NIH - Health Implications of Smokeless Tobacco, 27-31.

‘86 Edwards SW, Glover ED. Snuff & neuromuscular performance. American Journal of Public Health, 76(2):206.

‘86 Glover ED. Conducting smokeless tobacco cessation in clinics. American Journal of Public Health, 76(2):207.

‘86 Glover ED, Johnson R, Laflin M, Edwards SW, Christen AG. Smokeless tobacco trends among college students in the United States. World Smoking & Health, 11(1):4-9.

‘86 Glover ED, Alston PP, Edmundson EW. Prevalence of smokeless tobacco use in a North Carolina University. The North Carolina Journal, 22(1):19-20.

‘86 Glover ED, Edmundson EW, Edwards SW, Schroeder KL. Implications of smokeless tobacco use among athletes. The Physician & Sportsmedicine, 14(12):94-105.

‘87 Schroeder KL, Iaderosa GR, Chen MS Jr, Glover ED, Edmundson EW. Bimodal

initiation of smokeless tobacco usage: Implications for cancer education. Journal of Cancer Education, 2(1):1-7.

‘87 Laflin M, Glover ED, McKenzie J. Resources - Smokeless tobacco education. Journal of School Health, 57(5):191-194.

‘87 Glover ED, O’Brien K, Holbert D. Prevalence of smokeless tobacco use in Pitt County, North Carolina. The International Journal of the Addictions, 22(6):557-565.

‘87 Glover ED, Edwards SW. The impact of health education on health knowledge in Oklahoma.Oklahoma Journal of Health, Physical Education, Recreation & Dance, 19(1):14-16.

‘87 Edmundson EW, Glover ED, Alston PP, Holbert D. Personality traits of smokeless tobacco users &nonusers: A comparison. The International Journal of the Addictions, 22(7):671-683.

‘87 Edwards SW, Glover ED, Schroeder KL. The effects of smokeless tobacco & neuromuscular reactivity in athletes & nonathletes. The Physician & Sportsmedicine, 15(7):141-147.

‘87 Christen AG, Glover ED. History of smokeless tobacco use in the United States. Health Education,18(3):6-11, 13.

‘87 Glover ED, Edmundson EW, Holbert D, Alston PP, Schroeder KL. Prevalence & patterns of

smokeless tobacco use in a Southeastern University. Journal of Drug Education, 7(3):201 211.

‘88 Schroeder KL, Soller HA, Chen MS, Neal CJ, Glover ED. Screening for smokeless tobacco

associated lesions: Recommendations for the dental practitioner. Journal of the American Dental Association, 116:37-42.

‘88 Edmundson EW, Glover ED, Holbert D, Alston PP, Schroeder KL. Personality profiles associated with smokeless tobacco use patterns. Addictive Behaviors, 13:219-223.

‘88 Lotterhos JF, Glover ED, Holbert D, Barnes RC. Intentionality of college students regarding North Carolina’s 21-year drinking of law. International Journal of the Addictions, 23(6):629-647.

‘88 Schroeder KL, Milo AGC, Glover ED, Chen MS. Compounding variables & intentionality in longitudinal smokeless tobacco screening & intervention studies. Journal of Dental Research, 67(Spec Issue, Mar):315.

‘88 Glover ED, Schroeder KL, Henningfield JE, Severson HH, Christen AG. An interpretative review of smokeless tobacco research in the United States: Part I. Journal of Drug Education, 18(4):305-330.

‘88 Schroeder KL, Chen MS Jr, Iaderosa GR, Glover ED, Edmundson EW. Proposed definition of a smokeless tobacco user based on ‘potential’ nicotine consumption. Addictive Behaviors, 13:395-400.

‘88 Cinelli B, Glover ED. Nurses smoking in workplace: Causes & solutions. Journal of Community Health Nursing, 5(4):255-261.

‘88 Glover ED, Edwards SW, Laflin M, Albritton DL. Prevalence, intentionality, & age of initiation of smokeless tobacco use in Oklahoma. Wellness Perspectives, 5(4):3-6.

‘89 Glover ED, Schroeder KL, Henningfield JE, Severson HH, Christen AG. An interpretative review of smokeless tobacco research in the United States: Part II. Journal of Drug Education, 19(1):1-19.

‘89 Glover ED, Laflin M, Edwards SW. Age of initiation & switching patterns between smokeless tobacco & cigarettes among college students in the US. American Journal of Public Health, 79(2):207-208.

‘89 Boyd GM, Glover ED. Smokeless tobacco use by youth in the U.S. Journal of School Health, 59(5):189-194.

‘89 Schroeder KL, Neal CJ, Glover ED, Chen MS. Comparative Effects of smokeless tobacco & cigarettes on cardiovascular dynamics. Journal of Dental Research, 68(Spec Issue, Jun):918.

‘89 Glover ED, Laflin M, Flannery D, Albritton DL. Patterns of smokeless tobacco use among college students in American colleges. Journal of American College Health, 38(2):81-85.

‘89 Glover ED, Flannery D, Schroeder KL. The acute effects of moist snuff during submaximal exercise. Paavo Nurmi Congress Book, 50th Anniversary of the Finnish Society, 316.

‘89 Schroeder KL, Glover ED. Comparison of snuff & cigarettes on cardiovascular hemodynamics inyoung adults. Paavo Nurmi Congress Book, 50th Anniversary of the Finnish Society, 338.

‘89 Rose-Colley M, Eddy JM, Glover ED. Relapse prevention: Implications for health

promotion professionals. Health Values, 13(5):8-13.

‘89 Jackson SE, Chenoweth D, Glover ED, Holbert D, White D. Study indicates smoking cessation improves workplace absenteeism rate. Occupational Health & Safety, Dec :13,14-16,18.

‘89 Glover ED, Edmundson EW, White DM. Smokers & smokeless tobacco users: A

comparison of personality characteristics among collegiate males. Health Education,

20(7):37-40.

‘89 Eddy JM, Bibeau DL, Glover ED, Hunt BP, Westerfield RC. Wellness Perspectives Part 1: History, philosophy & emerging trends. Wellness Perspectives, 6(2):3-19.

‘90 Glover ED. P.L. 99-252: Its implications for public education. Journal of Public Health Dentistry, Winter 50(1):50.

‘90 Glover ED, Flannery D, Albritton DL, Scott LG. Smokeless tobacco: Questions & answers. Athletic Training, 25(1):10-16.

‘90 Glover ED, Holbert D, Alston PP, White DM, Edmundson EW. Personalities of current & ex-smokeless tobacco users. Health Values, 14(2):42-45.

‘90 Glover ED, Albritton DL, Mansfield C. Breaking the barriers: Strategies for a comprehensive tobacco control program. International Quarterly of Health Education, 10(3):223-229.

‘90 Glover ED, Edwards SW, Albritton DL, Flannery D. Variables associated with smokeless tobacco use among public school children. Oklahoma Journal of Health, Physical Education, Recreation & Dance, 20(5):21-23.

‘90 Flannery D, Glover ED, Airhihenbuwa C. Female circumcision: Traditional health practice or health concern Health Values, 14(5):34-40.

‘91 Chen MS, Schroeder KL, Glover ED, Bonaguro JA, Capwell EM. Tobacco use prevention in national school curricula: Implications of a stratified random sample. Health Values, 15(2):3-9.

‘91 Schroeder KL, Glover ED, Zebracki M. Comparison of snuff & cigarettes on cardiovascular

hemodynamics in young adults. The Global War Proceedings 7th World Conference on Tobacco & Health, 412-415.

‘91 Bouquot JE, Glover ED, Schroeder KL. Leukoplakia & smokeless tobacco keratosis are two separate precancers. In: Varma AD (ed). Oral Oncology. Delhi: MacMillan Indian, Ltd, 1991; 2:67-69.

‘91 The Nicoderm Study Group. Transdermal nicotine for smoking cessation: Results of two

multicenter controlled trials. Journal of the American Medical Association, Dec 11, 266(22):3133-3138.

‘92 Glover ED. Transdermal nicotine patch for smoking cessation. New England Journal of Medicine, Jan 30, 326(5):344.

‘92 Glover ED. Nicotine patches. The Medical Letter: On Drugs & Therapeutics, 38(868), April 17.

‘92 Glover ED, Glover PN. The smokeless tobacco problem: Risk groups in North America. Smokeless Tobacco or Health: An International Perspective. Monograph 2, USDHHS, PHS, NIH Pub No. 92-3461, pages 3-10.

‘92 Glover ED, Glover PN. Smokeless tobacco cessation & nicotine reduction therapy.

Smokeless Tobacco or Health: An International Perspective. Monograph 2, USDHHS,

PHS, NIH Pub No. 92-3461, pages 291-296.

‘93 Glover ED. What can we expect from the nicotine transdermal patch? A theoretical/practical approach. Health Values, 17(2):69-79.

‘94 Glover ED. Smokeless tobacco or spit tobacco an open letter to the Surgeon General. Health Values, 18(1):3-4.

‘94 Glover ED, Glover PN. Nicotine transdermal systems: How do nicotine patches work Health Values, 18(1):69-72.

‘94 Glover ED. The importance of methodology in assessing smoking cessation strategies. Modern Medicine, 62(1):17-21.

‘94 Repsher LR, Transdermal Nicotine Study Group. Smoking cessation by women & older persons: results from the Transdermal Nicotine Study Group. Modern Medicine, 62(1):34-38.

‘94 Glover ED, Wang M, Glover PN. Development of a high school smokeless tobacco cessation manual. Health Values, 18(2):28-33.

‘94 Glover ED (Contributing Author). U.S. Department of Health & Human Services. PreventingTobacco Use Among Young People: A Report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health & Human Services, Public Health Service, Centers for Disease Control & Prevention, National Center for Chronic Disease Prevention & Health Promotion, Office on Smoking& Health, 1994.

‘94 Glover ED. The Nicotine Vaporizer, Nicotine Nasal Spray, Combination Therapy, & the Future of Nicotine Replacement Therapy. Health Values, 18(3):22-28.

‘94 Glover ED, Lane SM, Wang MQ. The incidence of alcohol & recreational boating in Beaufort County, North Carolina. Wellness Perspectives, 10(3):37:43.

‘94 Glover ED, Glover PN, Franzon M. An exploratory pilot-study in smoking cessation among chronic obstructive pulmonary patients using a nicotine nasal spray. Journal of Addictive Diseases, 13(4):245.

‘95 Glover ED. OTC Nicotine Gum. The Journal of Family Practice, 40(1):15-16.

‘95 Glover ED, Lane SM, Wang MQ. Relationship of alcohol consumption & recreational boating in Beaufort County, North Carolina. Journal of Drug Education, 25(2):149-157.

‘96 Glover ED. Smoking cessation strategies. American Journal of Therapeutics, 3:358-363.

‘96 Glover ED, Sachs DPL, Stitzer ML, Rennard SI, Wadland WC, Pomerleau OF, Nowak

RT, Daughton DM, Glover PN, Hughes JR, Gross J. Smoking cessation in highly

dependent smokers with 4mg nicotine polacrilex. American Journal of Health Behavior,

20(5):319-332.

‘96 Hurt RD, Glover ED, Sachs DPL, Dale LC, Schroeder DR, Glover PN, Sullivan CR, Offord KP, Croghan IT, JA Johnston. Bupropion as An Adjunct to Smoking Cessation: A Double-Blind, Placebo-Controlled Dose Response Trial. American Society of Addiction Medicine Abstracts, 9th National Conference on Nicotine Dependence-Abstracts, p 137, 11A.

’97 Glover ED, PN Glover, Franzon M, Sullivan CR, Howell GM, Keyes G. A Nicotine Sublingual Tablet for Smoking Cessation: 6-Month Data. 10th World Conference on Tobacco or Health, Abstract Book, Aug 24-27, Beijing, China, 138.

‘97 Glover ED, Glover PN, Abrons HL, Franzon M. An exploratory study in smoking cessation among COPD patients using nicotine nasal spray. American Journal of Health Behavior, 21(4):310-317.

‘97 Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained-release bupropion & placebo for smoking cessation. New England Journal of Medicine, 337:1195-1202.

‘98 Glover ED, Leischow SJ, Rennard SI, Glover PN, Daughton D, Quiring JN, Schneider FH, Mione PJ.Lobeline sulfate for smoking cessation: a pilot study. American Journal of Health Behavior, 22(1):62-74.

’99 Daughton D, Fortmann S, Glover ED, Hatsukami D, Heatley S, Lichtenstein E, Repsher L, MillatmalT, Killen J, Nowak R, Ullrich F, Rennard S. The smoking cessation efficacy of varying doses of nicotine patch delivery systems four years to five years post quit day. Preventive Medicine, 28:113-119.

’99 Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, SachsDPL, Hurt RD. Effectiveness of bupropion for smoking cessation in subjects with a history of majordepression or alcoholism. British Journal of Psychiatry, 174:173-178.

’00 Glover ED, Tucker VL, Winter PDOB. Efficacy and tolerability of bupropion sustained-release for smoking cessation: a review of pivotal studies. The International Journal of

neuropsychopharmacology, 3:Supplement 1;S326.

’00 Goebel LJ, Crspo RD, Abraham RT, Masho SW, Glover ED. Predictors of smokeless tobacco use among Appalachian youth. Nicotine & Tobacco Research, 2:319-325

’01 Glover ED, Glover PN. Treating nicotine dependence. The West Virginia Medical Journal, 97:39-42.

’01 Glover ED, Glover PN. Pharmacological treatments for the nicotine dependent smoker. American Journal of Health Behavior, 25(3):179-182.

’01 Dale LC, Glover ED, Sachs DPL, Schroeder DR, Offord KP, Croghan IT, Hurt RD. Bupropion forsmoking cessation—predictors of successful outcome. Chest, 119:1357-1364.

’01 Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DPL, Grasela T, DeVeaugh-Geiss J. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Nicotine & Tobacco Research, 3(2):131-140.

’01 Glover ED, Tucker VL, Winter PD. Efficacy and tolerability of bupropion SR for smoking cessation. World Journal of Biological Psychiatry, 2(1)270S.

’02 Sullivan P, Sinz E, Hobbs G, Glover E, Cain J, Kofke A. Remifentanil Vs. Methohexital for electroconvulsive therapy. International Journal of Psychiatry in Clinical Practice, 6(4):254-255.

’02 Glover ED, Glover PN, Sullivan CR, Cerullo C, Hobbs GR. A comparison of sustained-release bupropion & placebo for smokeless tobacco cessation. American Journal of Health Behavior, 26;(5):386-393.

’02 Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CL, Howell RM, Keyes GG, Nilsson F, Hobbs GR. A comparison of a nicotine sublingual tablet & placebo for smoking cessation. Nicotine & Tobacco Research, 4:441-450.

’03 Sullivan P, Sinz E, Hobbs G, Glover ED, Cain J, Kofke A. Remifentanil Vs. Methohexital for electroconvulsive therapy. Journal of Electroconvulsive Therapy, 19(1):60.

’03 Glover ED, Glover PN, Payne TJ. Treating nicotine dependence. American Journal of Medical Sciences, 326(4):183-186.

’04 Glover ED. A new health education paradigm: uncommon thoughts about common matters. AAHE scholar address. American Journal of Health Education, 35(5):260-271.

’05 Glover ED, Nilsson F, Westin A, Glover PN, Laflin M. Developmental history of the Glover-Nilsson Smoking Behavioral Questionnaire (GN-SBQ). American Journal of Health Behavior, 29(5):443-455.

’05 Laflin M, Glover ED, McDermott RJ. Publication ethics: an examination of authorship practices. American Journal of Health Behavior, 29(6):579-587.

’05 Niaura R, Sayette M, Shiffman S, Glover ED, Nides M, Shelanski M, Shadel W, Koslo R, Robbins B, Sorrentino J. Comparative efficacy of rapid-release nicotine gum vs nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction, 100(11):1720-1730.

’05 Deprés JP, Golay A, Sjöström L, for the Rimonabant in Obesity-lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. New England Journal of Medicine, 353(20):2121-2134 November 17. (I served as a PI for one of the centers in the US and was listed in the Rimonabant In Obesity-lipids Study Group.)

’06 Glover ED. Successfully treating nicotine dependence: AAHPERD scholar address. American Journal of Health Education, 37(1):6-14.

’06 Gonzales D, Rennard SI, Nides M, Onchen C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR for the Varenicline Phase 3 Study Group.  Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized control trial.  Journal of the American Medical Association, 2006;296(1):47-55 (July 5). (I served as a PI for one of the centers in the US and was listed in the Varenicline Phase 3 Study Group.)

’06 Rennard SI, Glover ED, Leischow S, Daughton D, Glover PN, Muramoto M, Franzon F, Danielsson T, Landfeldt B, Westin A. Efficacy of nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine & Tobacco Research, 8(4):555-564.

’07 Glover ED, Glover PN, Laflin M, Nochur SV, Strnad JV. Sensitivity and specificity of a reagent-impregnated test strip in identifying smokeless tobacco users. Nicotine & Tobacco Research, 9(4):499-503.

’07 Glover ED, Laflin MT, Schuh KJ, Schuh L, Nides M, Christen AG, Glover PN, Strnad JV. A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction, 102:795-802.

’07 Glover ED, Rath JM. Varenicline: progress in the treatment of smoking cessation treatment. Expert Opinion Pharmacotherapy, 8(11):1757-1767. (Invited)

’07 Stevens AB, McDaniel KS, Glover ED, Wallace KS. Are instructions for over-the-counter nicotine replacement therapy readable? American Journal of Health Behavior, 31(Suppl 1):S79-S84.

’07 Dale LC, Ebbert JO, Glover ED, Croghan IT, Schroeder DR, Severson HH, Hurt RD. Bupropion SR for the treatment of smokeless tobacco use. Drug and Alcohol Dependence, 90(1):56-63.

’08 Nides M, Glover ED, Reus V, Christen AG, Make BJ. Varenicline versus bupropion or placebo for smoking cessation. American Journal of Health Behavior, 32(6):664-675.

‘08 Ebbert JO, Glover ED, Shinozaki E, Schroeder DR, Dale LC. Predictors of smokeless tobacco abstinence. American Journal of Health Behavior, 32(6):735-740.

‘10 Glover ED, Rath J, Sharma E, Glover PN, Laflin MT, Tønnesen P, Repsher L, Quiring J. A multi-center, phase-3 trial of lobeline sulfate for smoking cessation. American Journal of Health Behavior, 34(1):101-109.

’10 McDermott RJ, Glover ED. Formation and early history of The American Academy of Health Behavior. American Journal of Health Behavior, 34(5):563-572.

’11 Hatsukami DK, Jorenby DE, Gonzales D, Rigotti N, Glover ED, Oncken C, Tashkin D, Reus V, Akhavain R, Fahim REF, Kessler PD, Niknian M, Kalnik MW, Rennard SI. Immunogenicity and smoking cessation outcomes for a novel nicotine immunotherapeutic: anti-nicotine elicited antibodies enhance quitting and support long-term abstinence. Clinical Pharmacology Therapeutics, DOI 1038/clpt.2010.317.

‘11 Cooke CE, Glover ED, Xing S, Lee HY. Failure to obtain Varenicline in members with pharmacy benefits. The American Journal of Pharmacy Benefits, May/June 3(3):e36-e40.

’12 Kahn R, Gorgon L, Jones K, McSherry F, Glover ED, Anthenelli RM, Jackson T, Williams J, Murtaugh C, Montoya I, Yu E, Elkashef A. Selegiline transdermal system (STS) as an aid for smoking cessation. Nicotine & Tobacco Research, 14(3):March 2012;377-382. DOI:10.1093/ntr/ntr143.

’12 Ebbert JO, Severson HH, Danaher BG, Schroeder DR, Glover ED. A comparison of three smokeless tobacco dependence measures. Addictive Behaviors, 37(2012):1271-1277.

’14 McDermott RJ, Glover ED, Glover PN. Merging health behavior and policy to improve population health – a commentary. Health Behavior and Policy Review, 1(1):3-5. DOI:.

’14 Brotman RM, He X, Gajer P, Fadrosh D, Sharma E, Monogodin EF, Ravel J, Glover ED, Rather JM. Association between cigarette smoking and the vaginal microbiota. BMC Infectious Diseases. In press

Book & Film Reviews:

‘79 Glover ED. The impact of alcoholism. Journal of School Health, 49(2):112.

‘79 Glover ED. CASPER: Decisions about drinking. Journal of School Health, 49(10):579.

‘80 Glover ED. Dimensions of loss & death education. Journal of School Health, 50(3):168.

‘84 Glover ED. Comprehensive stress management. Journal of School Health, 54(7):261.

‘86 Glover ED. Kevin’s story. Journal of School Health, 56(5):194.

‘90 Glover ED. NCI Monograph - Smokeless tobacco use in the United States. Health

Education Research: Theory & Practice, 5(4):126.

Articles Non-Refereed (Trade Journals, Abstracts, Reprints):

‘77 Glover ED. No smoking in the galleries, please. Handball, 27(4):46-49.

‘78 Glover ED. Dangers of sidestream smoke. Astray, 1(3):1-3.

‘78 Glover ED. The influence of subliminal perception on smoking behavior. Dissertation Abstracts International, 38(9):1069.

‘78 Glover ED. The influence of subliminal perception on smoking behavior. Xerox University Microfilms, No. 78-1757.

‘78 Glover ED. The development, implementation & evaluation of a smoking & health

course. Resources in Education, SPO11959, ED 148751, ERIC Pub, Wash. DC

‘78 Glover ED. Sidestream smoke. Access, 1(5):26-28.

‘78 Glover ED. Can smoking decrease your handball efficiency? Handball, 28(6):49-51

‘79 Glover ED. The anatomy of a blister. Handball, 29(5):63-64.

‘80 Glover ED. Dissecting the blister. Racquetball Illustrated, 3(2):27-28.

‘80 Glover ED. Running from cigarettes - Part I. Texas Runner, 1(5):24-26.

‘80 Glover ED. Running from cigarettes - Part II. Texas Runner, 1(6):9,43.

‘80 Glover ED. Aspirin: Is it the next wonder drug for everyone Runner’s World, 15(4):67-70.

‘80 Landwer G, Glover ED. The runner’s enemy: Heat. Runner’s World, 15(5):72-74.

‘80 Glover ED. Removing sunburn’s sting. Runner’s World, 15(8):74.

‘80 Glover ED. A runner’s dilemma: Blisters. Texas Runner, 1(8):8-9.

‘81 Glover ED. Decreasing smoking behavior through subliminal stimulation treatments. Health

Education, 12(3):45.

‘81 Glover ED. The Texas school health education study. Published by a Texas Christian UniversityResearch Foundation Grant.

‘81 Glover ED. What is it like to be old Interchange, 10(2):2.

‘81 Glover ED. Higher education ain’t what it used to be. Image, 9(1):2-3.

‘82 Glover ED. Aspirin: Is it the next wonder drug for everyone? Runner’s World Presents...Fitness & Diet #2, 93-95,114.

‘83 Glover ED. The Texas school health education study. Resources in Education,

SPO21271, ED 148751, ERIC Publications, Wash. DC.

‘83 Glover ED. Dipping & chewing tobacco - an Oklahoma problem? OHEAC NEWS, 1(2):1-2,4.

‘83 Glover ED. House Bill 1816: Death of health education OHEAC NEWS, 1(2):1,3

‘83 Glover ED. Blisters. Reprinted in Your Good Health 1983.

‘83 Glover ED. Survey of health knowledge among Texas college freshman. Bibliographic

Index of Health Education Periodicals (BIHEP) 1983.

‘84 Christen AG, Glover ED & Harris NO. Dentistry: More than just drill, fill & bill. Editorial, HealthValues, 8(1):4.

‘85 Glover ED. Herpes: Removing fact from fiction. Reprinted in Sirs Sexuality, 2: Article number 33.

‘85 Glover ED. The smokeless tobacco epidemic. North Carolina AAHE Newsletter, 1(1):5.

‘86 Glover ED. Anatomy of smokeless tobacco. Public Administrator, 2(2):4.

‘87 Glover ED, Edmundson EW, Holbert D & Alston PP. Comparing the personality of the cigarettesmoker & smokeless tobacco user. Research Council Proceedings, SDAAHPERD, 4.

‘87 Lotterhos JF, Holbert D, Glover ED. University students’ intentions regarding the North Carolina 21-year drinking age law. The North Carolina Journal, 23(1):23.

‘87 Glover ED, Edmundson EW, Alston PP, Holbert D, Chenoweth DH, White DM. Personality profiles associated with dippers, chewers & nonusers of smokeless tobacco. The North Carolina Journal,23(1):24.

‘87 St. Pierre RW, Olsen LK, Glover ED. Overview of research related to smokeless tobacco use: Implications for community health practice. Abstracts: Pennsylvania Public Health Association, 25.

‘87 Lotterhos JF, Holbert D, Glover ED. The Impact of the North Carolina 21-year age law: One year later. NCAHPERD Annual Abstracts, 20.

‘88 Glover ED, Flannery D. Identifying patterns of moist snuff use among college males. Research Council Proceedings, SDAAHPERD, 1988; 43.

‘88 Lotterhos JF, Holbert D, Glover ED. The impact of the North Carolina 21-year drinking age law: One year later. The North Carolina Journal, 24(1):16.

Books, Manuals, Chapters, Reports, Guides, Tapes:

‘77 Glover ED. Taxonomy of Psychological Abstracts on Smoking 1968-1976 Inclusive,

American Cancer Society, Kansas Division

‘77 Glover ED, Hull B. Topics & Laboratory in Smoking Cessation & Prevention: A

College Curriculum Guide, American Cancer Society, Kansas Division

‘79 Glover ED. Tobacco use & the breath of life. Chapter, Healthier Living, 4th Ed, John

Wiley & Sons, Instructor’s Manual

‘83 Glover ED. Personal Health Behaviors. Oklahoma State University Press

‘85 Glover ED, et al. Health Education for Life. Published by the State Board of Education,

State of Oklahoma

‘87 Glover ED. A conversation with Dr. Elbert Glover on smokeless tobacco. Balance Video

Productions, Portland, Maine

‘87 Glover ED, Schroeder KL, Scott L. Teacher’s written supplements, smokeless tobacco. Balance Video Production, Portland, Maine

‘87 Glover ED, Winn DM, Schroeder KL, Hunter SM. Anatomy of smokeless tobacco.

Society of Behavioral Medicine tape

‘87 Glover ED, Coughlin J. Community action against smoking. American Medical

Association Auxiliary tape, Chicago

‘88 Glover ED. Smokeless tobacco. 30-minute video, American Cancer Society, North

Carolina Division

‘88 Glover ED. Smoking or health. 30-minute video, American Cancer Society, North

Carolina Division

‘88 Glover ED. Training facilitators in conducting Freshstart: A quit smoking program.

30-minute video, American Cancer Society, North Carolina Division

‘88 Glover ED. Physiological effects of cigarette smoking. 25-minute video, Proctor & Gamble

‘88 Glover ED. Is smokeless tobacco hazardous? Slide presentation, American Lung

Association, North Carolina Division

‘90 Glover ED. Smokeless tobacco cessation: A self-help management program for high

school students. American Cancer Society, Inc

‘91 Glover ED & others. Nicotine dependence & smoking cessation. Slides for Medical

Information Services, NY

‘92 Glover PN, Glover ED. Start SMART. A supervised, medication assisted nicotine

reduction therapy program

‘94 Glover ED & others. Smoking the new vital sign status: A smoking cessation kit for

health professionals. Medical Information Services, NY

‘95 Glover ED, Glover PN. Smokeless Tobacco. Chapter in The Encyclopedia of Drugs

& Alcohol, Macmillan Publishing Company, NY

‘96 Glover ED, Glover PN, Nett L, Shiffman S, Small RE, Tommasello A. Pharmacy Practice Guidelines for the OTC Era: The Pharmacists’ Role in Smoking Cessation. Medical Information Services, Inc., NY

’02 Glover ED. Chewing and smokeless tobacco, snuff. Encyclopedia of Public Health, Macmillan Publishing Company, NY.

HONORS & LISTINGS:

‘77 Awarded Scholarship, Kansas Social Rehabilitation Services, Drug Abuse Unit & the Midwestern Area Alcohol Education & Training Program (Chicago) to attend the Midwest Prevention Evaluation Workshop, Nashville, TN

‘77 Awarded Trip, National Public Education Conference, American Cancer Society, Honoring Cancer Volunteers, Chicago

‘77 Nominated, National Award in Public Education, American Cancer Society for the Development of a Smoking & Health Course

‘78 Awarded Copyrights, Technique of Influencing Cigarette Smoking Behavior Through Subliminal Stimulation, Registration Number 145-534

‘80 Selected Outstanding Young Man of America, U.S. Jaycees

‘80 Awarded Health Education Writer’s Award, Central Michigan University & Upjohn Pharmaceutical Company, Second Best Health Education Article Written in 1979

‘80 Named by Nutshell Magazine of the College Community, One of the Nine Most Innovative Educators in America

‘82 Awarded, the Sword of Hope Award, Outstanding Volunteer Service in the State of

Texas, American Cancer Society

’85 Visiting Scholar, Presson Lecturer, Murray State University

’87 Visiting Scholar, Appalachian State University

’87 Visiting Scholar, Western Carolina University

’87 Visiting Scholar, University of Northern Iowa

‘87 Selected, National American Cancer Society Office to Develop National Prevention & Cessation Smokeless Tobacco Materials

‘87 Invited, by NCI to Celebrate 50th Anniversary for Contribution to Tobacco Research, Bethesda, MD

’88 Visiting Scholar, Pennsylvania State University

‘90 Selected, Distinguished Alumnus for Health Education, Texas Woman’s University, Denton, TX

‘91 Contributor, the American Stop Smoking Intervention Study (ASSIST) received by West Virginia. ($4.8 million dollars, 7-year partnership between the state health department & the American Cancer Society).

’00 Awarded, Lifetime Achievement Award, American Academy of Health Behavior, 2000

’01 Awarded, The Robert D. Russell Visiting Scholar, Southern Illinois University, Carbondale, IL.

’01 Awarded, Faculty Research Award for 2001, West Virginia University School of Medicine, Department of Behavioral Medicine & Psychiatry

’03 Awarded, AAHE Scholar, American Association for Health Education, Philadelphia, PA

’03 Selected, President’s Visiting Scholar, University of California-Chico, Chico, CA

’03 Invited, Distinguished Visiting Lecturer, Texas A&M University, College Station, TX

’05 Awarded, Alliance Scholar, AAHPERD, Chicago, IL

’05 Presidential Commendation, American Academy of Health Behavior, Charleston SC

‘05 Service Award, Society for Research on Nicotine and Tobacco, Prague, CZ

’07 Named, “Rainmaker” a University Research Leader by the University of Maryland, Division of Research for research dollars awarded

’07 Named, Charter Contributor, by the University of Maryland School of Public Health for

contributions to the Formation of the University of Maryland School of Public Health

’08 Awarded, The 2008 Research Laureate Medallion by the American Academy of Health Behavior for Contributions to Health Behavior Research, Oxnard, CA

RESEARCH GRANT AWARDS:

‘76 Awarded, Small Grants Subcommittee, Faculty Senate Committee, University of Kansas,

Subliminal Perception & Smoking. (PI) $1,820

‘77 Awarded, Kansas Lung Association, Decreasing of Smoking Behavior through

Subliminal Stimulation. (PI) $1,500

‘77 Awarded, American Cancer Society, Kansas Division, Smoking & Health, Curriculum Materials. (PI) $5,245

‘77 Awarded, State Social Rehabilitation Services, Drug Abuse Unit, Balancing Head & Heart –

Sensible Ideas for the Prevention of Drug Abuse. (PI) $3,933

‘77 Awarded, Faculty Senate Research Committee, University of Kansas. Subliminal Perception & Smoking Behavior. (PI) $1,130

‘78 Awarded, Texas Christian University Research Foundation. The Texas School

Health Education Study. (PI) $2,200

‘79 Awarded, Texas American Cancer Society, Smoking & Health. (PI) $4,700

‘80 Awarded, PHS, CDC, Bureau of Health Education, Administered by Texas

Department of Health. Prevention of Alcohol & Tobacco Use Related Problems Among

Middle School Students. Co-PI, with AH Henderson. Two-year Project, Oct. $129,597

‘83 Awarded, Dean’s Starter Grant Program, Oklahoma State University, Oklahoma

Health Education Study. (PI) $2,555

‘83 Awarded, Dean’s Starter Grant Program, Oklahoma State University, Effect of

Smokeless Tobacco on the Performance of Selected Perceptual Motor Skills. (PI) $2,490

‘83 Awarded, Dean’s Starter Grant, Oklahoma State University, Smokeless Tobacco

Use in Oklahoma. (PI) $2,189

‘84 Awarded, Oklahoma Health Systems Agency, The Prevalence of Smokeless

Tobacco in Oklahoma Public Schools. (PI) $7,700

‘87 Approved, NCI, Smokeless Tobacco Prevention: An Interdisciplinary Approach.

Co-PI, with KL Schroeder & MS Chen Jr. $1,499,210 (Approved, not funded)

‘89 Awarded, American Cancer Society, Evaluation of a High School Self-Help

Brochure for Smokeless Tobacco Cessation. (PI) $4,500

‘89 Awarded, Merrell Dow Pharmaceuticals, The Evaluation of the Safety & Efficacy

of Nicorette 4mg as an Aid for Cessation of Cigarettes In Highly Dependent Smokers.

(PI) $158,293

‘89 Awarded, ALZA Corporation, A Placebo-Controlled Study Assessing the Safety &

Relative Efficacy of Two Dosing Regimens of a New Transdermal Nicotine System.

(PI) $219,314

‘90 Awarded, LEO Pharmaceuticals (Sweden), Nicotine Inhaler (Nicohaler) Versus

Placebo in Smoking Cessation: A Clinical Evaluation. (PI) $381,800

‘91 Awarded, Ohio Heart Association, Comparative Cardiovascular Effects of Heavy

Usage in Male Smokeless Tobacco Users & Cigarettes Smokers. (Co-I; KL

Schroeder, PI). $22,500

‘92 Awarded, KABI Pharmacia AB (Sweden), A Pilot Study Assessing the Nicotine

Nasal Spray (NNS) as a Pharmacological Adjunct for Smoking Cessation & Prevention in

Chronic Obstructive Pulmonary Disease (COPD) Patients. (PI) $49,500

‘92 Awarded, Marion Merrell Dow, Treatment Strategies for Nicotine Addiction. (PI) $20,000

‘93 Awarded, U.S. Department of Education, Building Resilience in High-Risk

Elementary Students Grades 4-8. (Co-PI; M Laflin, PI) $275,000

‘94 Awarded, Research Testing Laboratories & Ciba-Geigy Pharmaceuticals, A

Validation Study to Determine the Ability of Cigarette Smokers with Six Specified Medical

Conditions to Understand the Need to Consult a Physician Before Using the Habitrol OTC Product. (PI) $4,500

‘94 Awarded, Marion Merrell Dow, 4-Year Follow-up on the Nicotine Transdermal

Trial for Smoking Cessation. (PI) $4,000

‘94 Awarded, DynaGen, Inc., Evaluation of NicErase-SL for Smoking Cessation in

Healthy Volunteers. (PI) $630,930

‘94 Awarded, Burroughs Wellcome, A Multicenter Dose Response Evaluation of

Wellbutrin (Bupropion Hydrochloride) Sustained-Release Versus Placebo as an Aid to

Smoking Cessation. (PI) $387,164

‘94 Awarded Continuation Grant, U.S. Department of Education, Piecing Together the Future –

Promoting Resilience in Children & Adolescents: Strategies for the Prevention of Alcohol & Tobacco Use. (Co-PI, M Laflin, PI) $275,000

‘94 Awarded, DynaGen, Inc., A Pilot Phase 3 Study of NicErase-SL for Smoking

Cessation. (PI) $100,000

‘94 Awarded, Centers for Disease Control, Implementing Smoking Cessation in a Rural Setting.

(PI) $192,500 (3 1/2-year grant)

‘95 Awarded, National Cancer Institute & Personal Improvement Computer Systems, Computer

Assisted Smokeless Tobacco Cessation. (PI) $101,150

‘95 Awarded, Ciba Consumer Pharmaceuticals, Double-Blind Evaluation of Waking

Hour Usage of Habitrol vs. Placebo Patches. (PI) $83,895

‘96 Awarded, Pharmacia Upjohn, A Double-Blind Placebo Controlled Clinical & Safety Evaluation of a Nicotine Sublingual Tablet in a Smoking Cessation Setting. (PI) $311,000

‘96 Awarded, DynaGen Inc., A Pivotal Phase 3 Study of NicErase-SL for Smoking

Cessation. (PI) $323,500

’97 Awarded, Sano, The Evaluation of the Efficacy & Safety of a Transdermal Delivery System of

Nicotine/Mecamylamine in Cigarette Smokers. (PI) $224,742

’97 Awarded, Sano, The Evaluation of Continuous Abstinent at 3, 6, & 12 Months after the Quit

Date in Nicotine/Mecamylamine Transdermal Studies. (PI) $54,675

’97 Awarded, DynaGen Inc., Determination of the Sensitivity of the NicCheck I Test in Identifying the Use of Smokeless Tobacco (PI) $8,400

’97 Awarded, Sano, The Evaluation of the Efficacy & Safety of a Transdermal Delivery System of

Nicotine/Mecamylamine in Cigarette Smokers with a History of Hypertension who Are Maintained on Anti-Hypertensive Pharmacotherapy. (PI) $31,909

’97 Awarded, Sano, The Evaluation of the Safety of a Transdermal Delivery Systems of

Nicotine/Mecamylamine in Cigarette Smokers in Patients with Gastrointestinal Disorders. (PI) $89,011

’98 Awarded, Glaxo Wellcome, A Multicenter Evaluation of the Effects of Zyban (bupropion

sustained release tablets) versus Placebo in a Population of Smokers with COPD. (PI) $139,440

’98 Awarded, Glaxo Wellcome, A Multi-Center, Double-Blind, Double-Dummy, Placebo-

Controlled, Randomized, Parallel Group, Dose Response Evaluation of 1555U88 (2.5mg/day, 5mg/day, 10mg/day) & ZYBAN→ (bupropion hydrochloride) Sustained Release versus Placebo As Aids to Smoking Cessation. (PI) $582,900

’99 Awarded, SmithKline Beecham Consumer Healthcare, A Randomized, Double-Blind, Parallel Group Study to Measure the Efficacy & Safety of Nicotine Gum (2 mg & 4 mg) for Smoking Cessation by Gradual Reduction. (PI) $90,620

’99 Awarded, Glaxo Wellcome, A Double-Blind Placebo Controlled Clinical & Safety

Evaluation of Zyban for Smokeless Tobacco Cessation. (PI) $58,458

’99 Awarded, Knoll Pharmaceutical Company, A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy & Safety of Meridia (sibutramine hydrochloride) Plus Adjunctive Nicotine Therapy (Habitrol Patch) as an Aid for Smoking Cessation in Patients who Smoke Cigarettes. (PI) $347,040

’99 Awarded, Bristol-Myers Squibb, A Multi-Center, Double-Blind, Placebo-Controlled Study to

Evaluate the Efficacy of Buspirone as an Aid to Smoking Cessation. (PI) $180,000

’99 Awarded, Pharmacia & Upjohn, A Double Blind, Randomized, Placebo-controlled Multicenter Trial of a Nicotine Inhaler in Smoking Reduction: A 15-month Trial. (PI) $288,225

’99 Awarded, Synthelabo Research, Inc. Comparison of the Efficacy & Safety of 3 Oral Doses of Befloxatone 2.5 mg/day, 5 mg/day & 10 mg/day Versus Placebo as an Aid to Smoking Cessation in Smokers: A Randomized, Double-blind, 6-month Multicenter Phase II Trial 10-week Active Treatment—3.5 Month Follow-up. (PI) $399,750

’99 Awarded, Glaxo Wellcome, A Multicenter, Double-Blind, Placebo-Controlled Comparison of the Safety & Efficacy & Effects on Sexual Functioning of Wellbutrin (Bupropion HCL) Sustained Release (SR) & Fluoxetine Outpatients with Moderate to Severe Recurrent Major Depression. (Co-PI, with JM Stevenson, MD) $190,800

’99 Awarded, Glaxo Wellcome, A Multicenter, Randomized, Parallel, Placebo-controlled, One-Year Study of the Efficacy & Safety of Zyban (bupropion HCL sustained release tablets) versus Placebo as Aids to Smoking Cessation Treatment in Adult Cigarette Smokers Previously Treated with Bupropion. (PI) $76,044

’00 Awarded, Eli Lilly & Company, Open-Label Combination of Olanzapine & Fluoxetine in Major Depressive Disorder. (Co-PI, with CR Sumner, MD) $223,353

’00 Awarded, Pfizer Inc, A Seven-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety & Efficacy of Three Doses of CP-526,555 (0.3mg QD, 1mg QD, & 1mg BID) in Comparison with Zyban SR in Smoking Cessation. (PI) $599,500

’00 Awarded, Sanofi-Synthelabo, A Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of SR141716 as an Aid to Smoking Cessation. (PI) $386,400

’01 Awarded, Parke-Davis, A 6-Week, Double-Blind, Randomized, Multicenter, Flexible-Dose, Placebo-Controlled Study of Pagoclone In Patients with Generalized Anxiety Disorder. (PI) $121,000

’01 Awarded, Takeda, A Randomized Comparator, Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCL Versus Glyburide with Metformin and Insulin as Part of Step Therapy in Subjects with Type 2 (Non-Insulin Dependent) Diabetes. (Co-PI, with J Selby, MD) $155,574

’01 Awarded, Healthcare Products Development Inc., A Randomized, Multi-center, Open-label Study to Assess the Comparative Time-dependent Efficacy of CR Nicotine Gum to Nicorette in Relieving Acute Craving Following Exposure to Smoking Cue-induced Craving in Adult Volunteer Cigarette Smokers Who Smoke 10 to 24 Cigarettes Per Day. (PI) $122,000

’01 Awarded, DrugAbuse Sciences Inc., An Open Label, 12-Month Safety Study of Naltrexone Depot in Treatment of Alcohol Dependence. (PI) $128,325

’01 Awarded, Pfizer, A 6-Week, Double-Blind, Randomized, Multicenter, Fixed-Dose, Placebo-Controlled Study of Pagoclone Dosed Once a Day in Patients with Generalized Anxiety Disorder. (PI) $122,500

’01 Awarded, Sanofi-Synthelabo Grant, A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter, Study of Weight-Reducing Effect and Safety of SR 141716 in Obese Patients with Untreated Dyslipidemias. (PI) $121,420

’02 Awarded, Year I, National Institutes of Health (NIH-1R01 CA90884-01A1). Efficacy of Bupropion for Treating Spit Tobacco Users. (Co-I); Lowell Dale, MD, PI, Mayo Clinic) $2,792,992

’02 Awarded, Sanofi-Synthelabo, Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5mg/day or 20mg/day, versus Placebo, as an Aid to Smoking Cessation – A Single Country, Randomized, Double-blind, 3-Arm, Placebo-controlled, Parallel-group, Fixed Dose, 52-week Multi-center, Phase III trial; 2-week Screen, 10-week Treatment, 40-week Follow-up. (PI) $665,550

’02 Awarded, Genaissance, A Case Control Investigation Exploring the Relationship between Gene Variants (HAP™ Markers) and Agranulocytosis or Granulocytopenia in Adult Patients Treated with Clozapine. (Co-I; JM Stevenson, MD, PI) $4,250

’02 Awarded, Eli Lilly & Company Grant, Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine HCL in Children & Adolescents with ADHD and Comorbid Anxiety Disorder. (Co-I, JM Stevenson, MD, PI) $194,706

’03 Awarded, Pfizer, Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study with Follow-Up Evaluating the Safety & Efficacy of Varenicline Tartrate (CP-526,555) in Comparison to Zyban for Smoking Cessation. (PI) $816,500

’03 Awarded, Sanofi-Synthelabo, Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 4 mg/day or 20 mg/day Versus Placebo as an Aid to Prevention of Relapse to Smoking - a Multiple Country (Worldwide), Randomized, Double-Blind, 3-arm, Placebo-Controlled, Parallel-Group, Fixed Dose, 2-Year, Multicenter, Phase III Trial: 1-Year Active Treatment, 1-year-Followup. (PI) $421,874

’03 Awarded Year 2, National Institutes of Health (NIH-1R01 CA90884-01A1). Efficacy of Bupropion for Treating Spit Tobacco Users. (Co-I; L Dale, MD, PI, Mayo Clinic) $2,792,992

’03 Awarded, Sanofi-Synthelabo, A Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of One Fixed Dose of SR58611A (700 mg/day) Versus Placebo and Paroxetine (20 mg/day) in Patients with a Recurrent Major Depressive Episode. (Co-I; W Byrd, MD, PI) $124,900

’03 Awarded, Sanofi-Synthelabo, A Dose-Ranging Placebo-Controlled Study of SL64.0155-10 at the Doses of 0.5 mg, 2 mg, and 8 mg for 12 Weeks in Patients with Mild-to-Moderate Alzheimer’s Disease. (Co-I; K Curci, MD, PI) $102,000

’04 Awarded, AstraZeneca, A Multicenter, Randomized, Parallel-group, Double-blind, Phase III Comparison of the Efficacy & Safety of Quetiapine Fumerate (oral tablets 400 mg to 800 mg daily in divided doses) to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients. (Co-I; J Stevenson, MD, PI) $360,000

’04 Awarded, Sanofi-Synthelabo Comparison of the Efficacy & Safety of 3 Oral Doses of SSR591813, 20 mg, 40 mg, 80 mg Twice Daily, Versus Placebo as an Aid to Smoking Cessation. A US, Multicenter, Randomized, Double-blind, 4-arm, Fixed Dose, 7-week Treatment, Phase II Trial. (PI) $295,750

’04 Awarded, Campbell University, Evaluation of 24 Hours Motor Activity of Bupropion XL vs Placebo in Patients with Major Depressive Disorder. (PI) $57,000

’04 Awarded Year 3, National Institutes of Health (NIH-1R01 CA90884-01A1). Efficacy of Bupropion for Treating Spit Tobacco Users. (Co-I; L Dale, MD, PI, Mayo Clinic) $2,792,992

’04 Awarded, Sanofi-Synthelabo, A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy & Safety of Rimonabant 20 mg versus Placebo on Weight Loss & Frequency of Binge Episodes in Obese Patients with Food Craving. (PI) $43,880

’05 Awarded, GlaxoSmithKline, Cortical Myelin Preservation in Schizophrenic Patients. (Co-I; W Byrd, PI) Investigator Initiated Project, $120,000

’05 Awarded, Bristol Myers Squibb, A Multicenter, Long-Term, Open-Label Study to Assess the Safety and Tolerability of Aripirazole as Adjunctive Therapy in the Treatment of Outpatients with Major Depressive Disorder. (PI) $247,286

’05 Awarded, Sanofi-Aventis, An Eight-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients with Major Depressive Disorder. (PI) $183,400

’05 Awarded, National Institute of Drug Abuse, Appalachian TriState Node of Clinical Trials Network Research Project. 5-Year Study (2005-2009). (Co-I, for WV site, M Byrne, PI). $651,493

’06 Awarded, NABI Pharmaceuticals, A Phase 2, Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Immunogenicity of Two doses of 3'-aminomethylnictone-P. aeruginosa r-Exoprotein A Conjugate Vaccine (NicVax) in Two Different Dosing Schedules in Smokers Who Want to Quit. (PI) $330,624

’06 Awarded, Pharmacia & Upjohn Company LLC (Pfizer), A Multi-center, Randomized, Parallel Group, Comparative Trial to Evaluate the Efficacy of Nicotine Hydrogen Tartrate Gum (4m) and a Coated Nicotine Polacrilex Gum (4mg) Versus Uncoated Nicotine Polacrilex Gum (4mg) on the Speed to Subjectively Meaningful Relief of Acute Craving in Adult Smokers. (PI) $372,300

’06 Awarded, Sanofi-Aventis, An International, Seven-Week, Double-Blind, Placebo-Controlled Two Parallel Group Study to Assess the Efficacy of SSR591813L 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers. (PI) $340,000

’06 Awarded, National Institute of Drug Abuse & the Department of Veterans Affairs, Phase 2, Double-Blind, Placebo-Controlled Trial of Selegiline as an Aid to Smoking Cessation. (PI) $634,988

’06 Awarded, Pinney Associates and Concentrics, Study to Assess the Efficacy of 4mg Nicotine Lozenge vs. Varenicline in Relief of Provoked Craving. (PI) $191,800

’07 Awarded, Pfizer Inc, Phase I, Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Multiple-dose Pharmacokinetics, Safety & Tolerability of Varenicline in Healthy Adolescent Smokers. (PI) $40,639

’08 Awarded, Nabi Pharmaceuticals, A Study to Assess Efficacy of NicVax in Smokers Who Want to Quit Smoking. (PI) $19,500

’09 Awarded, Nabi Pharmaceuticals, A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy, Immunogenicity and Safety of 3’-aminomethylnicotine-/P. aeruginosa/ r-Exoprotein A Conjugate Vaccine (NicVAX® ) as an Aid to Smoking Cessation. (PI) $413,675

’10 Awarded, University of Maryland-College Park and the University of Maryland-Baltimore Research Program, Interaction of the Human Microbiome and Tobacco in Women’s Reproductive Health. (Co-PI; R Brothman) $75,000

’10 Awarded, Nabi Pharmaceuticals, Health-Related Quality of Life and Health-Care Resource Utilization Assessment in Nabi 4514 and Nabi 4515 Phase 3 Studies. (PI) $9,900

’11 Awarded, Nabi Pharmaceuticals, A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Follow-up Safety Study to Assess Long-term Immunogenicity and Safety of 3’-aminomethlnicotine-P. aeruginosa r-Exoprotein Conjugate Vaccine (NicVax) as an Aid to Smoking Cessation. (PI) $63,173.41

’11 Awarded, Pfizer Inc, A Phase 4 Randomized Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Re-treatment with Varenicline in Subjects Who are Currently Smoking, and Have Previously Taken Varenicline. (PI) $365, 293

’13 Awarded, National Institutes of Health (NIH), Rapid Response Characterization of New and Manipulated Tobacco Products. P50-CA-180890-01 (Pamela I Clark, PI; ED Glover, Co-Investigator, Director of Research Training and Education Core D. $18,770,000 over 5 years.

’14 Awarded, McNeil Health Care, A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Using A Naturalistic Clinical Model To Measure The Efficacy And Safety Of A Novel Nicotine Replacement Therapy In Smokers Motivated To Quit. (PI) Negotiating budget

-----------------------

October 24, 2014

[pic]

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download